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This PhD project has been structured into three parts preceded by a general introduction on 
basic biocatalysis concepts. 
Part 1: The recombinant preparation coupled with biochemical and structure characterization 
a thermostable carboxylesterase (BCE) from Bacillus coagulans NCBI 9365. This enzyme 
showed high enantioselectivity towards different 1,2-O-isopropylideneglycerol esters 
(acetate, butyrate and benzoate). Both enantiopure of 1,2-O-isopropylideneglycerol (IPG or 
solketal), a chiral equivalent of glycerol, are building blocks for the synthesis of -blockers, 
glycerophospholipids and prostaglandins. 
Part 2: An insight on the biocatalytic potential of Acetic Acid Bacteria (AAB), a group of 
bacteria well-known for the ability to oxidize primary and secondary alcohols into partially 
oxidized organic compounds (aldehydes, carboxylic acids and ketones) as end-products. 
This part collect three chapters: 
 the stereoselective desymmetrisation of achiral 2-alkyl-1,3-diols performed by 
oxidation of one of the two enantiotopic primary alcohol moieties by means of 
Acetobacter aceti MIM 2000/28 free whole cells to afford the corresponding chiral 
2-hydroxymethyl alkanoic acids in batch system 
 Chemoenzymatic flow synthesis of enantiomerically pure captopril, a widely used 
antihypertensive drug, with the particular focus on the enzymatic step carried on 
with immobilized cells of Acetobacter aceti MIM 2000/28 used in a continuous flow 
reactor. 
 Productivity and stability of the air-liquid flow system setted up in the previous 
work, has been studied and optimized, through the use of immobilized form 
Acetobacter aceti MIM 2000/28 in the oxidation of 2-metyl-1,3-propandiols. To 
verify the real efficiency of the system, the experiment with other substrate will be 
carried out.  
Part 3: Hydroxylation of (R)-limonene into (R)-perillyl  alcohol studied using recombinant 
whole cells harbouring an optimized redox gene operon (CYP153A6) which encodes a 
cytochrome P450, a ferredoxin, and a ferredoxin reductase from Mycobacterium sp. HXN-
1500- 
 Questa tesi di Dottorato è stata strutturata in tre parti, una per ogni tipo di attività enzimatica 
trattata, preceduta da una breve introduzione riguardante i principi fondamentali della 
biocatalisi. 
Parte 1: Sono state studiate le caratteristiche strutturali e biochimiche dell’esterasi (BCE) 
prodotta per via ricombinante da Bacillus coagulans NCBI 9365. Questo enzima mostra un 
elevato grado di selettività nei confronti degli esteri (acetato, butirrato e benzoato) dell’1,2-
O-isopropilidenglicerolo (IPG) un acetale equivalente chirale del glicerolo, che in entrambe 
le configurazioni, è un utile prodotto di partenza per la sintesi di molecole naturali 
biologicamente attive di interesse alimentare e farmaceutico come gliceridi, 
glicerofosfolipidi, -bloccanti ed antiipertensivi 
Parte 2: Sono state studiate le potenzialità biocatalitiche di batteri acetici, microrganismi noti 
per la loro capacità di accumulare prodotti di ossidazione (aldeidi, chetoni e acidi 
carbossilici) dati dalla trasformazione di alcoli primari e secondari. Questa parte risulta 
ulteriormente suddivisa in tre capitoli: 
 La desimmetrizzazione stereoselettiva di dioli achirali diversamente sostituiti, è 
stata eseguita ottenendo i corrispettivi acidi chirali utilizzando, cellule intere di 
Acetobacter aceti MIM 2000/28  
 È stata studiata la sintesi chemo-enzimatica della forma enantiopura del captopril, 
noto farmaco utilizzato per il trattamento dell’ipertensione. Particolare attenzione è 
stata dedicata allo step enzimatico catalizzato da cellule immobilizzate di 
Acetobacter aceti MIM 2000/28 utilizzate in un sistema in continuo di “flow 
chemistry”. 
 La produttività e la stabilità del sistema di ossidazione “flow chemistry” è stato 
studiato e ottimizzata attraverso l’utilizzo del 2-metil 1,3 propandiolo. Per testare la 
reale efficienza del sistema in continuo messo a punto, sono in corso di studio le 
prove effettuate con ulteriori substrati. 
Parte 3: L'idrossilazione del (R) -limonene in (R)-alcool-perililico è stata studiata attraverso 
l’utilizzo di cellule intere ricombinanti di E. coli trasformate con l’operone sintetico 
ottimizzato che codifica per una citocromo P450 monossigenasi (CYP153A6), una 
ferredossina e una ferredossina reduttasi isolate dal ceppo Mycobacterium sp. HXN-1500 
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The economic growth requires safe and sustainable resources for industrial production. With 
the aim to move to a new economic model, based on the use and re-use of raw material, 
completely new approaches in research, production and economy are necessary. The key 
point of the change depends on how far it is possible to switch production of material and 
services gradually from the limited resources to renewable ones. 
Circular economy and Bioeconomy 
The economic linear system (Fig.1), characterized by the “take-make-dispose” concept, 
represent the prevalent model, based on use of input derived by cheaper but limited 
resources. In the last few years, the increase in the request of these kind of raw materials, 
underlined their significant limits, questioning the current economic system based on a linear 
approach. 
 
Fig. 1 Schematic representation of linear economic model 
 
The circular economy (Fig.2) concept has developed as result of the crisis of the traditional 
pattern. This economy model is based on recycle and reuse of all resources, even those 
considered waste, giving them a high added value. The Ellen MacArthur Foundation defines 
the circular economy as a resource-efficient system that is “life-imitating”: inputs and 
outputs are used in a circular way so that outputs ultimately become inputs again1. 
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Fig. 2 Schematic representation of circular economic model 
 
The circular economy is based on three principles (Fig 3): 
• Principle 1: Preserve and enhance natural capital 
• Principle 2: Optimise resource yields 
• Principle 3: Improve system effectiveness  
The circular economy is a model built to “auto-regenerate”. The key point is composed by 
the biological and technical cycle, which include all processes that are able to add value to 
waste materials. It is also a kind of economy able to “restore” because is based on the used 
renewable energy and sources in order to minimize the waste production and uses of 
polluting substances. Moreover, the circularity of economy not only concerns about the 
possibility to re-use, recycle and regenerate the waste material (defined “leakages” of the 
different stage of production), but also the possibility to prevent the leakages accumulation, 
reducing and regulating the flow and the quantity of raw material incoming in economic 
system2. 
14 
 
 
Figure 3 Outline of a circular economy approach 
 
Bioeconomy is defined by John Bell, Director of Bioeconomy Directorate of the European 
Commission, as the “biological heart” of circular economy3. If the circular economy focuses 
for the most part on the efficient use of all kind of resources and ensures that those are reused 
and recycled as long as possible, the bioeconomy deals with the use of renewable biological 
resources. In particular, this model refers to the use of biomass for the production of 
biomaterials and bioenergy. In this contest biomass is considered as the biodegradable 
fraction of products, waste and residues of biological origin from agriculture (including plant 
and animal substances), forestry and related industries, including fisheries and aquaculture, 
as well as the biodegradable part of industrial and urban waste. The principle of the circular 
economy is thus complementary to the renewable character of the bioeconomy, contributing 
to create a sustainable economic growth 
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According to the vision of this economic model, biorefining represents a great way to obtain 
large-scale and sustainable development of biomass use, resulting in the production of 
biobased materials and bioenergy with optimal socio-economic and environmental impacts4. 
Among the several definition of “biorefinery”, the most exhaustive was recently performed 
by the IEA Bioenergy Task 42 :“Biorefining is the sustainable processing of biomass into a 
spectrum of marketable products and energy”5. More in detail, we can consider the 
biorefinery system as an industrial facility or a network of facilities that use a broad range 
of technologies able to run the full sustainable transformation of biomass resources into their 
building blocks, which can be converted to value added products, biofuels and chemicals. 
Moreover, the system has to be able to combine the material flows in order to reach a 
complete utilization of all biomass components. In this context, the residue from one bio-
industry (e.g. lignin from a lignocellulosic ethanol production plant) becomes an input for 
other industries, giving rise to integrated bio-industrial systems in order to obtain full 
optimization of renewable resources6. 
A forward looking approach is the stepwise conversion of large parts of the global 
economy/industry into a sustainable biobased society having bioenergy, biofuels and 
biobased products as main pillars and biorefineries as the basis. Such a replacement of 
limited resources with renewable one will require some breakthrough changes in the today’s 
production of goods and services: biological and chemical sciences will play a leading role 
in the generation of future industries and new synergies of biological, physical, chemical and 
technical sciences must be developed6. 
The role of green chemistry 
The use of green chemistry principles and low environmental impact technologies into 
biorefineries is mandatory7. We can consider the green chemistry as the area of chemistry 
that provide the guidelines for the manufacture and application of products that aim to 
develope sustainable chemical synthesis strategies limiting use, or generation, of 
environmentally detrimental and hazardous chemicals. 
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The twelve principle of green chemistry (Fig.4) published from Anastas and Warner8, 
represent the set of concepts with the aim to optimize the following aspects of a chemical 
process: 
 Chemical efficiency: reducing the 
waste formation, minimizing the 
number of reagents atoms that take part 
in the reaction, minimizing the number 
of derivatives (limiting the work up 
required) and using starting materials 
deriving from renewable sources. 
 Energetic efficiency: with catalysts, it’s 
possible to reduce the use of cooling 
and heating required during the 
reactions. 
 Safety: using reagents that are less toxic 
and less prone to create dangerous 
situations, using available knowledge 
to predict the toxicity characteristics of 
the newly synthetized compounds. 
 
The overall aim of green chemistry combined with biorefinery concept is the production of 
“eco-friendly” and sustainable chemical products9. Green chemistry offers a protocol when 
developing biorefinery processes and may play an important role in facilitating production 
of commodity chemicals from biomass. In accordance with green chemistry principles, 
during chemical product manufacture, and indeed during the whole product life cycle, 
energy demands should be minimized, safer processes used, and hazardous chemical use and 
production avoided. The final product should be non-toxic, degradable into innocuous 
chemicals and with minimum production of waste. 
Fig.4 The twelve principles of green chemistry 
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Bioprocesses and bioeconomy 
A relevant role in biorefinery and green chemistry is played by biotechnological processes, 
where microorganisms and enzymes are used to convert residues and by-products from 
biomasses into molecules of interest in different areas10,11. 
Bioprocesses can be classified into fermentation and biocatalysis. Fermentation usually 
refers to the use of growing cells to make the products of interest; biocatalysis may broadly 
be defined as the use of biological catalysts (biocatalysts), which can be isolated enzymes or 
whole cells, used in their free or immobilised form. Fermentation technologies are usually 
used in large molecules production, such as enzymes, peptides, therapeutic proteins (e.g. 
antibodies and insulin) and proteins used in the food industry (e.g. feed additives), but also 
small molecules, such as metabolites of fermentation processes, e.g. ethanol, 1,3-
propanediol, succinic acid and butanol12. Biocatalytic processes are used for the preparation 
of chemicals (small molecules) such as building blocks for added-value chemicals, amino 
acids, agrochemicals and active pharmaceutical ingredients (APIs), often being 
complementary to conventional chemical processes13. 
Modern biocatalysis 
New biocatalytic processes offer an increasing potential for the production of goods to meet 
various human needs. The driving forces in the development of the industrial enzyme 
technology are:  
 the obtainment of new products or processes to meet these needs; 
 the improvement of the quality of processes for the preparation of existing products 
starting from raw materials. 
Both these approaches may lead to an innovative product or process that is not only 
competitive, but also meet sustainability criteria14. 
The main advantage in the use of biocatalysts are summarized below15: 
• Chemo- regio- and stereoelectivity; 
• Catalytic efficiency; 
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• Mild reaction conditions; 
• Sustainability; 
• One-pot multienzymatic reactions; 
• Protein ability to accept a broad range of organic molecules. 
On the other hand, some of these same advantageous traits of enzymes may also constitute 
their limitations:16 
• Narrow operational window; 
• Low productivity; 
• Low number of commercially available biocatalyst; 
• High time required for the development of an industrial process; 
• Cofactor-depending enzymes; 
• Enzyme enantiospecificity; 
• Catalyst recovery and reuse. 
To overcome these issues several techniques have been developed in order to obtain better 
biocatalytic processes17, working on the biocatalyst improvement (screening from non-
conventional sources, improved recombinant systems, protein and metabolic engineering, 
biocatalyst immobilization) or on the process development (operation mode and reactor 
selection). 
Screening of biocatalyst  
The whole process that sees the industrial application of a new enzyme usually begins with 
in vivo (using experimental assay to test the enzymatic function) or in silico screening (based 
on enzyme sequence/structure). In the last years, a large effort has been devoted to the 
identification of new biocatalysts from extremophile microorganisms (particularly 
thermophiles), since operation at high temperatures (above 45-50 °C) minimizes the risk of 
microbial contamination in industrial processes. Moreover, some reactions are favoured at 
relatively high temperatures (an example is the isomerization of glucose to fructose), 
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although care should be taken to avoid an operational environment that may lead by-product 
formation. The majority of enzymes used is of terrestrial microbial origin, and screening-
efforts for isolation of promising enzyme producing strains have accordingly been 
performed in such background18. From some years now, marine environments have also 
been tapped as a source for useful enzymes from either microbial or higher organisms 
origin19.  
Biocatalyst form 
According to the kind of reaction is possible to choose to use whole cells or purified enzymes 
as biocatalyst. Usually, the use of whole cells is favoured in reactions where the use of 
cofactors is necessary, since the cellular system provides cofactors and systems for their 
recycling, avoiding their addition to the reaction mixture. However, due to the possibility of 
side reactions, the use of whole-cells may require additional downstream process costs for 
product recovery.  
Isolated enzymes are particularly interesting for synthetic routes, due to their selectivity and 
purity of product stream. Additionally, the use of isolated enzymes brings simplicity to the 
process (avoiding undesired side reactions) but the trade-off is higher upstream costs (for 
enzyme recovery and purification)20 and therefore re-use of the enzyme is often required to 
design an economically competitive process.  
As a balance between these trade-offs (and as a rule of thumb), the crudest possible form of 
the enzyme (e.g. whole-cell or lysate) should be used, without compromising the product 
quality21. 
Large-scale biocatalytic processes require the use of immobilised biocatalyst, in order to 
easily recycle and reuse the biocatalyst22. The use of immobilized form of biocatalyst allows 
to obtain a cleaner product stream, avoiding not only undesired by-products, but also the 
protein contamination. Moreover, recycling and versatility in use in continuous processes is 
also needed for the process economic viability, in order to compensate for a costly upstream, 
comprising not only enzyme recovery and purification but also the immobilisation step23.  
Table 1 reports the summary of possible advantages and disadvantages of the different form 
of biocatalysts: 
20 
 
Table 1 Different advantages and disadvantages of whole cells and isolated enzyme 
Biocatalyst Form Advantages Disadvantages 
 
Isolated 
enzymes 
 
Dissolved in 
water 
 
 Simple apparatus 
 Simple work-up 
 Better productivity 
 High substrate 
concentration 
tolerance 
 High catalytic 
activity 
 
 Cofactor recycling 
necessary 
 Side reaction possible 
 Lipophilic substrates 
insoluble 
 Workup requires 
extraction 
 
Suspended in 
organic solvents 
 
 Easy to perform 
 Simple workup 
 Lipophilic substrates 
soluble 
 Easy enzyme 
recovery 
 
 Reduced catalytic 
activity 
 
Immobilized 
 
 Easy enzyme 
recovery 
 Enzymatic recycling  
 
 Possibility to use 
continuous flow 
reactors 
 
 Loss of activity during 
immobilization 
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Whole cells  
Growing cultures 
or resting cells 
 
 No cofactor 
recycling necessary 
 High activity 
 Simple workup 
 Fewer by-products 
 
 Expensive equipment 
 Tedious workup 
 Low productivity 
 Low substrate 
concentration tolerance 
 Low organic solvents 
tolerance 
 Uncontrolled side 
reactions  
Immobilized 
cells 
 
 Possible cell re-use 
 Use in continuous 
flow reactors 
 
 Loss of activity during 
immobilization 
 
Biocatalyst characterization 
The characterization of biocatalyst is usually done through the investigation of enzyme kinetics 
parameters. In particular, activity assays are usually used to study the effect on reaction rate of 
changes in temperature, pH, ionic strength, enzyme and other components concentration. The 
results have not always been presented in a rate law, but have most often provided a useful starting 
point for more detailed studies by fixing some of the environmental variables such as ionic 
strength, pH and temperature. Experiments have usually been carried out by mixing all 
components together at the same time and thereafter monitoring the development of the individual 
component concentrations. The rate of reaction has then been defined as either the disappearance 
or production of a component over time. The initial testing of enzymes usually includes an 
investigation of the linear activity/enzyme concentration range and the optimal pH. After this has 
been established, enzyme concentration can be fixed to obtain subsequently measured initial rates 
in a reasonable time period. The pH is then also fixed in accordance with the highest activity 
observed, which usually also represents the most stable condition for the enzyme. 
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Another important feature of biocatalysts is their operational stability, which can be influenced by 
different parameters (temperature, pH, co-solvents, buffers with high ionic strength etc.). 
Immobilization is a solution for improving enzyme stability over time. Immobilized biocatalysts 
(either isolated enzymes or whole cells) are more resistant to destabilizing agents, since access to 
the enzyme is limited; moreover, immobilization introduces new interactions between the protein 
and the support, which may stabilize the tertiary structure of the enzyme. Loss of quaternary 
structure can be also partially avoided by cross-linking unbound subunits to those already bound 
to the support. 
Protein and metabolic engineering 
Some of the research efforts have focused on the biochemical and molecular mechanisms 
underlying the stability of enzymes from extremophiles. This kind of knowledge is also 
particularly useful for protein engineering of known enzymes, aiming at enhancing stability, 
substrate specificity without compromising catalytic activity24. The upgrading of this feature 
is of paramount importance for implementation of industrial processes, since it allows for 
reducing the amount of enzyme used in the process.  
Two methodologies can be used for protein engineering: 
i. The first methodology involves rational pinpoint modifications in one or more 
amino acids are made, where these changes are predicted to bring along the envisaged 
improvement in the targeted enzyme function.  
ii. The second is the directed evolution of enzymes, through random mutagenesis and 
recombination. This methodology, which allows for a high throughput, has been extensively 
applied, aiming for more efficient biocatalysts.  
Process engineering  
Another aspect to consider in the optimization of biocatalytic process is the choice of 
bioprocess mode that depend on features of biocatalyst and of the reaction. It is possible 
distinguish three different kind of operation mode: 
 Batch: this mode provide that all the reagents are fed into the reactor and the work 
up is done when the reaction is completed. However, this type of operating mode is 
not suitable for cases where a strong substrate inhibition is observed.  
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 Fed-batch: with this mode the substrate is added in a periodic or continuous way, 
while the product is recovered in the end of the process.  
 Continuous: the reagents are continuously fed into the reactor and product is 
continuously recovered. This implies that the reactor is operating at the effluent 
substrate feed-rate. 
The choice of the reactor depends on different features such as cost, space, mass transfer, 
kinetics, heating and cooling, easiness of operation, operation mode and reusability of 
the catalyst25. 
In table 2 the most common reactors with their advantages and disadvantages are listed26: 
 
Table 2 Different reactors for multi-enzymatic processes 
Reactor 
type 
Reactor 
representation 
Advantages Disadvantages 
S
ti
rr
ed
 t
an
k
 r
ea
ct
o
r 
(S
T
R
) 
 
Allows soluble and immobilised 
enzymes and whole-cell 
Multiphase media 
Good operational control 
Simple modelling 
Simple construction 
Low downtime (easy to clean) 
Possible 
inactivation 
of biocatalyst 
Difficult 
soluble 
enzyme 
recycling 
P
ac
k
ed
 b
ed
 r
ea
ct
o
r 
(P
B
R
) 
 
Allows soluble and immobilised 
enzymes and whole-cell 
Low enzyme damage due to shear 
stress 
High conversions achieved and 
volumetric productivities 
Shorter residence times 
Easy enzyme recycling, 
separation and 
exchange 
Low investment cost 
Thermal 
gradient 
Difficult to 
control 
Complex 
modelling 
Mass transfer 
limitations 
Not suitable for 
multiphase 
reactions 
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F
lu
id
iz
ed
 b
ed
 r
ea
ct
o
r 
(F
B
R
) 
 
Allows soluble and immobilised 
enzymes and whole-cell 
Good enzyme mixing 
Suitable for multi-phase reactions 
Lower pressure drop 
Uniform flow field 
Good operational control 
Easy enzyme recycling, 
separation and 
exchange 
Possible 
inactivation of 
biocatalyst. 
Constrained by 
the particle size 
and density 
M
em
b
ra
n
e 
b
io
re
ac
to
r 
(E
M
R
) 
 
Allows soluble enzymes 
Low enzyme damage due to shear 
stress 
High conversions achieved 
In-situ separation 
Retention of enzymes and 
cofactors 
Dosing of a reagent 
Compartmentalisation 
Complex 
modelling 
Poor control 
Membrane 
fouling 
Restrictions on 
the volumetric 
flow rate 
High energy 
utilisation 
B
u
b
b
le
 c
o
lu
m
n
 
re
ac
to
r 
(B
C
R
) 
 
Simple design 
High heat transfer area 
Low enzyme damage due to shear 
stress 
Low maintenance costs 
High sparging 
rates 
are required for 
a 
turbulent flow 
Bubble 
coalescence 
 
. 
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Example of biocatalytical process: FOS 
production  
FOSs are linear oligosaccharides of fructose containing a single glucose (G) moiety in which 
fructosyl units (F) are bound at the β(2→1) position of a sucrose molecule (GF). Among 1-
FOSs, 1-kestose (GF2), 1-nystose (GF3), and 1-β-fructofuranosylnystose (GF4) represent 
the most studied and used compounds (family 1, Fig 5). Other FOSs families founded in 
commercial functional foods are 6-FOSs (family 6, Fig 5) and neo-FOSs (family neo, Fig 
5)27. 
 
Fig.5 FOS stuctures (families 1, 6 and neo) 
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Zambelli et al.,28 al reported the screening of different filamentous fungi isolated from 
molasses and jams (kiwi and fig) for fructooligosaccharides (FOS) producing activity. 
Starting from 45 strain, two strains have been selected evaluating fructooligosaccharides 
(FOS) producing activity and considering the FOS yield and kestose/nystose ratio. In 
particular, using 600 g/L of sucrose, maximum FOS yield was 184 and 339 g/L for P. 
sizovae and C. cladosporioides, respectively. Interestingly, the highest FOS 
concentration with C. cladosporioides was reached at 93% sucrose conversion, which 
indicated a notable transglycosylation to hydrolysis ratio. 
In a following work29, they aimed to demonstrate the advantages in the use a flow-
chemistry reactor with previously described biotransformation. With the final aim of 
predisposing a suitable process for the sustainable and scalable production of the desired 
FOS mixture, whose potential use as a novel prebiotic preparation can be easily foreseen 
and is at present under investigation by us. Process has been developed using a process 
in a continuous set-up. In particular, to this aim, a C. cladosporioides MUT 5506 strain 
was used as an immobilized mycelium in a packed bed reactor to improve the 
productivity, the efficiency and the scalability of the reported batch biotransformation. 
The innovative application of whole microbial cells into a flow chemistry reactor 
combines the advantages of an easy to produce biocatalyst with a process-intensification 
technology. Moreover, the use of a continuous-flow approach based on a packed bed 
reactor guarantees improved mass transfer and recyclability of the solid catalyst. 
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Aim of the project 
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The interest in the use of biocatalysts is due to its advantages in terms of specificity, ability 
to operate under mild conditions of pH, temperature and pressure, high activity and turnover 
numbers, and high biodegradability. The whole may contribute for developing sustainable 
and environmentally friendly processes.  
The main topic of my PhD project has been the study and the characterization the following 
biocatalysts activity: 
-  Esterase activity of a thermostable carboxylesterase from Bacillus coagulans (BCE) with 
high enantioselectivity towards different 1,2-O-isopropylideneglycerol esters (acetate, 
butyrate and benzoate); 
- Oxidation activity of Acetobacter aceti MIM 2000/28 used to catalyse the stereoselective 
desymmetrisation of achiral 2-alkyl-1,3-diols; 
- Hydroxylation activity of limonene monooxigenase isolotated from Mycobacterium sp. 
strain HXN-1500 able to product (R)-perillyl alcohol starting from (R)-limonene. 
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Abstract  
Microbial carboxylesterases are biocatalysts that hydrolyze an extensive range of 
structurally different esters. Here, we report the recombinant preparation and biochemical 
characterization of an atypical carboxylesterase from Bacillus coagulans (BCE), able to 
enantioselectively hydrolyze different 1,2-O-isopropylideneglycerol (IPG or solketal) esters. 
In all the cases, BCE efficiently produces enantioenriched (S)-IPG, a versatile chiral building 
block usable for the synthesis of different compounds of nutritional and pharmaceutical 
interest (i.e., -blockers, glycerophospholipids and prostaglandins).The enzymes showed a 
remarkable thermophilicity, with the highest activity observed at 65° C. BCE showed a 
typival non-lipolytic behavior, being able to hydrolyze short-chain esters and showing no 
activity on laurate and palmitate esters; moreover, no interfacial activation was observed 
using tributyirin. The crystal structures of BCE was solved in apo- and glycerol-bound forms 
at resolutions of 1.9 Å and 1.8 Å, respectively. In silico docking studies on the BCE structure 
validated the experimental data, indicating that only small acyl chains (<C6) IPG esters may 
be hydrolyzed and that enantioselectivity may be the result of an enhanced stabilization of 
the tetrahedral intermediate for the S-enantiomer.  
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Introduction 
Carboxylesterases (EC 3.1.1.1) catalyze the cleavage and formation of carboxyl ester bonds, 
being often classified as esterases and lipases, depending on experimental data and 
theoretical hypotheses. Recently, it has been suggested to simply organize carboxylester 
hydrolases into lipolytic esterases (proposed EC: L3.1.1.1) and non-lipolytic esterases 
(NLEst, proposed EC: NL3.1.1.1) [1].  Databases, such as the Lipase Engineering Database 
(LED), the α/β-hydrolase Fold Enzyme Family 3DM or ESTHER [2-4] are available for 
further classification. Carboxylesterases are useful biocatalysts, especially for the 
enantioselective hydrolysis or synthesis of chiral and prochiral esters  [5-7].  
Bacteria of the genus Bacillus are known for the production of carboxylesterases [8]. B. 
subtilis [9-14], B. coagulans [15], B. amyloliquefaciens [16], B. stearothermophilus [17], 
and generic Bacillus sp. [18] have been identified as producers stereoselective lipases and 
esterases.  
Enantioselective hydrolysis of racemic esters of 1,2-O-isopropylideneglycerol (IPG or 
solketal) is a convenient method for producing optically pure IPG [9, 15, 19-24], a valuable 
chiral building block for the synthesis of -blockers, glycerophospholipids, and 
prostaglandins [25]. However, lipases are poor enantioselective biocatalyst in the hydrolysis 
of IPG esters; in a screening using commercial lipases, Amano AK lipase (from 
Pseudomonas sp.) proved the only one with good enantioselectivity towards (R,S)-IPG 
octanoate, but with low yields (22% after 48 h ), while ester with shorter chain gave lower 
enantioselectivity [25]. Other lipases, such as Candida antartica lipase B (Novozyme 435), 
were poorly enantioselective towards IPG esters [26]. 
A carboxylesterase from B. coagulans (BCE) with medium-to-high enantioselectivity 
towards racemic esters of IPG [5, 4] and other chiral esters [27] was previously identified 
and purified. The appealing thermophilicity and stereoselectivity of the enzyme led us to 
further investigate its biochemical and structural features. 
In this context, crystal structures of BCE were solved with high resolution (1.8-1.9 Å), in its 
apo-form and in complex with glycerol. Our functional studies showed that BCE works as a 
non-lipolytic carboxylesterase and hydrolyzes C2-C8 esters, with maximum activity towards 
caproate (C6) esters, and catalyze the production of optically pure (S)-IPG from racemic 
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mixtures of butyrate and benzoate IPG esters. BCE showed highest activity at 65°C, showing 
typical Michaelis-Menten kinetics and has no apparent requirement for interfacial activation 
when tributyrin was used as substrate. This non-lipolytic behavior differs from structural 
observations that indicate the presence of a large lid domain typical of lipases. Structural 
analyses of this non-conventional carboxylesterase are presented in relation to its non-
lipolytic catalytic function and stereoselectivity for butyrate and benzoate IPG esters.  
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Materials and methods  
Production of recombinant BCE 
The BCE gene coding for the full-length protein was amplified from Bacillus coagulans 
strain NCIMB 9365 genomic DNA by PCR using the following primers:  
Forward: 5'-CACCATGTTGGCTTTTCAAGAGTTGAG-3';  
Reverse:  5'-TGAGCTCGAGTCATTTTACGATGATCCCGTT-3'.  
The amplified gene was cloned into the pET100/D-TOPO® vector (Invitrogen) in frame with 
a N-terminal six-histidine tag, according to the manufacturer's instructions. Correct construct 
sequence was confirmed by DNA sequencing. 
Cultures of BL21(DE3)Star E. coli cells were transformed with the resulting plasmid and 
grown overnight at 37 °C in LB medium supplemented with 100 mg/L ampicillin. The seed 
culture was then diluted into 1.0 L Erlenmeyer flasks containing 100 ml Luria Broth (LB) at 
an initial OD600nm of 0.1. Cultivation was carried out at 37 °C with agitation at 150 rpm. Cells 
were grown until an OD600nm of 0.8. After cold-shock treatment, cultures were induced with 
0.5 mM IPTG (isopropyl--D-thiogalactopyranoside) and further incubated for 16 h at 20 
°C. Bacterial cells were harvested by centrifugation at 5000 rpm for 15 min, washed once 
with 20 mM sodium phosphate buffer at pH 7.0 and stored at -20 °C.  
The cell pellet was suspended in 50 mM Tris-HCl pH 8.0 containing 100 mM NaCl, 6 mM 
imidazole. Bacterial cells were lysed by sonication (5 cycles of 30 s each, in ice, with 1 min 
interval) and the supernatant was harvested by centrifugation at 15,000 rpm for 45 min at 4 
°C. BCE was purified from the supernatant by affinity chromatography with HIS-Select 
Nickel Affinity Gel (Sigma-aldrich) pre-equilibrated with 50 mM Tris-HCl pH 8.0, 
containing 100 mM NaCl, 6 mM imidazole. After a washing step with 50 mM Tris-HCl pH 
8.0, 100 mM NaCl, 6 mM imidazole, His-BCE was eluted with 50 mM Tris-HCl pH 8.0, 
100 mM NaCl, 250 mM imidazole.  
For crystallization trials, BCE was purified from a 0.5 L bacterial culture on a 5 mL Bio-
scale Mini Profinity IMAC cartridge using the Profinia Protein Purification System (Bio-
rad), following standard Bio-rad protocols. Purified BCE was exchanged into crystallization 
buffer (10 mM Tris-HCl pH 8.0; 150 mM NaCl) using a PD10 desalting column (GE 
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Healthcare), according to the manufacturer's instructions and concentrated to 6.5 mg/mL, 
using an Amicon Ultra-15 centrifugal filter (Millipore) with a MW cut-off of 10 kDa. 
Biotransformations and esterase activity assays 
Biotransformations of IPG esters were carried out in 5 mL screw capped tube, using 7 mU 
of BCE in 1 mL of 50 mM Tris-HCl pH 8.0, 100 mM NaCl. The substrates were added at 
the final concentration of 5 mM, dissolved in DMSO at a final concentration of 0.5%. 
Incubations were carried out with magnetic stirring at 30°C. Conversions and stereochemical 
outcomes were monitored by gas chromatography using a chiral capillary column (diameter 
0.25 mm, length 25 m, thickness 0.25 μm, DMePeBeta-CDX-PS086, MEGA, Legnano, 
Italy) with a 0.25 mm-diameter, 25 m-length and 0.25 m-thickness, using the following 
temperature gradients: for IPG acetate: 10 min at 90 °C, increased to 120 °C over 15 min, 
maintained at 120 °C for 10 min and then increased to 180 °C over 2 min and then 
maintained at 180 °C for 10 min; for IPG butyrate: 10 min at 90 °C, increased to 110 °C 
over 5 min, maintained at 110 °C for 10 min and then increased to 180 °C over 2 min and 
then maintained at 180 °C for 10 min;  for IPG benzoate: 10 min at 90 °C, increased to 
120 °C over 3 min, maintained at 120 °C for 10 min and then increased to 180 °C over 2 min 
and then maintained at 180 °C for 10 min. Retention times of IPG enantiomers and esters 
under these conditions were: (R)-IPG= 8.2 min, (S)-IPG= 9.0 min; (R)-IPG 
acetate = 13.1 min, (S)-IPG acetate = 12.4 min; (R)-IPG butyrate =22.3 min, (S)-IPG 
butyrate = 21.2 min; (R)-IPG benzoate = 27.7 min, (S)-IPG benzoate = 27.5 min.  
 
 Enantiomeric excesses (e.e.) were calculated using the following formulas: 
e.e.substrate = ([(S)-IPG ester] - [(R)-IPG ester])/ ([(S)-IPG ester] + [(R)-IPG ester]) 
e.e.product  = ([(S)-IPG] - [(R)-IPG])/ ([(S)-IPG] + [(R)-IPG]) 
 
Hydrolysis of IPG benzoate was also performed on semi-preparative scale: 250 mg (1.06 
mmol) of substrate were dissolved in DMSO (1 mL) and added to 199 mL of 50 mM Tris-
HCl pH 8.0, containing 100 mM NaCl. Upon addition of BCE (7 mU mL-1), the reaction 
was followed by gas-chromatography and stopped after 50 min (in correspondence to a 60% 
conversion). The reaction was stopped by adding 100 mL ethyl acetate (EtOAc) to recover 
both unreacted (S)-IPG benzoate and enantiomerically pure (S)-IPG. The aqueous phase was 
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extracted by repeating the addition of EtOAc twice. Organic extracts were collected, dried 
over sodium sulfate and the solvent removed under reduced pressure. Flash chromatography 
(n-hexane/EtOAc, 75/25) on silica gel pretreated with triethylamine afforded 52 mg of 
optically pure (S)-IPG (ee > 99% by chiral GC). 
The activity of the BCE (0.036 mg mL-1) was measured spectrophotometrically using 0.015 
mM p-nitrophenyl acetate as a substrate dissolved in 0.3% acetone, monitoring the increase 
in absorbance at 400 nm, corresponding to the production of p-nitrophenol (extinction 
coefficient 15000 M-1 cm-1). Assays were conducted at 25°C in a microcuvette in a final 
volume of 1 mL of 50 mM Tris-HCl pH 8.0, 100 mM NaCl, following the reaction for 5 
min. One unit of BCE corresponds to the amount of protein that produces 1 μmol of p-
nitrophenol in 1 min. 
Kinetic analyses of BCE activity 
The kinetic parameters were measured spectrophotometrically using different 
concentrations of p-nitrophenyl esters (acetetate, butyrate, caproate, caprylate, laurate, and 
palmitate) at 28°C in 1 mL of 50 mM Tris-HCl pH 8.0, NaCl 100 mM (final 0.3% acetone), 
monitoring the increase of absorbance at 400 nm due to the production of p-nitrophenol 
(15000 M-1cm-1). Experimental data were fitted to suitable kinetic models with Origin 9.0 
and kinetic parameters (Vmax, Km) were calculated with the same program.  
Hydrolysis of tributyrin (in the range of 0.1-2.0 mM) was measured titrimetrically at 28 °C 
with a pH-stat using 30 mL of phosphate buffer 10 mM, pH 7.0.  
BCE crystallization 
Crystallization trials of BCE (6.5 mg/mL) were prepared in 96-flat well sitting drop 
plates (Greiner), containing 100 μL crystallization solution of PACT 
PremierCrystallization screen (Molecular Dimensions). 400 nL drops were 
deposited at diverse protein concentrations (30, 50 and 70 % of the stock protein 
solution) and crystals grew after approximately 1 week in several conditions. Data 
for the apo-enzyme were collected on a single crystal grown in condition 2-11 (20% 
PEG3350; 0.1 M sodium citrate tribasic hydrate); the crystal was cryoprotected in 
50% PEG3350. Data for the glycerol-bound form of BCE were collected on a single 
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crystal grown in condition 42 (1.5 M ammonium sulfate, 12% glycerol and 0.1 M 
Tris-HCl, pH 8.0) of Hampton Crystal Screen II (Hampton Research). For 
cryoprotection the concentration of glycerol was raised to 25%. 
Data Collection, model building and refinement 
X-ray diffraction Data were collected at the ID29 (glycerol-bound enzyme), ID23-1 (apo-
enzyme) beamlines at the European Synchrotron Radiation Facility (ESRF, Grenoble, 
France). Data were processed using XDS and assigned to the hexagonal P6322 space group 
using POINTLESS and scaled using AIMLESS, available in the CCP4i suite [38-40]. The 
3D structure of BCE was solved via molecular replacement using BALBES and the protein 
sequence as the input; the BALBES search model was based on the structure of human 
monoglyceride lipase (PDB entry 3PE6) [28, 41]. The initial model was refined with 
PHENIX.refine, including a translational-libration-screw (TLS) option, final Rgen and Rfree 
values of 21 and 24.3% (apo-BCE) and 14.7 and 16.9% (glycerol-bound BCE) were reached, 
respectively (Table 3). Both final models present ideal geometric parameters, with 97.7% 
(apo-BCE) and 98.1% (glycerol-bound BCE) residues assigned to the most favorable regions 
of the Ramachandran plot, with no outliers, according to structure validation using 
MolProbity under the Phenix platform (Table 3).  
Circular dichroism  
Circular dichroism measurements were performed with a J-810 spectropolarimeter (JASCO 
Corp., Tokyo, Japan) equipped with a Peltier system for temperature control. All 
measurements were performed in crystallization buffer (10 mM Tris-HCl pH 8, 150 mM 
NaCl) at a protein concentration of 0.2 mg/mL, and in a 0.1 cm path length cuvette. 
Temperature ramps experiments were monitored at a wavelength of 220 nm (temperature 
slope 1°C/min). Tms were calculated as the maximum of the first-derivative of the traces. 
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Results  
Production of recombinant BCE 
The gene coding for BCE (accession number WP_029142894) was amplified from B. 
coagulans NCIMB 9365 genomic DNA and cloned into the pET100/D-TOPO® bacterial 
expression vector. N-terminal His-tagged BCE fusion protein was produced in Escherichia 
coli BL21(DE3)Star cells, as described in the Experimental Procedures. Expression levels 
were determined by SDS-PAGE (data not shown) and by measuring enzyme activity 
(U/mg), monitoring the conversion of p-nitrophenyl acetate (pNPA) to p-nitrophenol. The 
highest specific activity was measured after induction with 0.5 mM IPTG for 16 h at 20°C 
in Luria-Bertani (LB) broth.  
BCE was purified by affinity chromatography and exchanged into 50 mM Tris-HCl pH 8.0, 
100 mM NaCl for activity assays, as described in the Experimental Procedures. BCE 
migrated on a 11% polyacrylamide gel at a molecular weight of 50 kDa, consistent with the 
calculated molecular mass of the full-length protein (39.2 kDa) plus the N-terminal His-tag 
(8.8 kDa). Under optimized conditions, 20 mU/mg of BCE was obtained, corresponding to 
a volumetric productivity of approximately 350 mU/L culture and to a specific productivity 
of 80 mU/g wet biomass. 
BCE activity and enantioselectivity 
BCE exhibited high activity towards pNPA between 45 and 65°C in 50 mM Tris-HCl pH 
8.0 containing 100 mM NaCl; the highest activity was observed at 65°C. BCE was active at 
a pH range from 7.0 to 9.0.  
The ability to hydrolyze substrates with longer acyl chains was also investigated using p-
nitrophenyl butyrate (C4), caproate (C6), caprylate (C8), caprate (C10), laurate (C12), and 
palmitate (C16) (Figure 1). 
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Figure 1. BCE activity towards p-nitrophenyl esters. Relative activity refers to the activity 
in presence of p-nitrophenyl caproate (100%) and represents the arithmetic mean and 
standard deviation (SD) of three measurements. 
 
BCE showed typical non-lipolytic behavior, being able to hydrolyze C2-C8 esters following 
typical Michaelis-Menten kinetics, with a maximum activity towards caproate ester (see 
Table 1 for kinetics data), whereas no activity was detected towards laurate and palmitate 
esters. The absence of interfacial activation was also confirmed by measuring the activity of 
BCE over a range of tributyrin concentrations (0.1-2.0 mM).  
 
Table 1. Kinetic parameters of hydrolysis of p-nitrophenyl esters catalyzed by BCE. 
Substrate kcat (s-1) KM (mM) 
acetate (C2) 0,621 (± 0.095) 0.873 (± 0.010) 
butyrate (C4) 0.264 (± 0.025) 0.049 (± 0.006) 
caproate (C6) 0.211 (± 0.020) 0.021 (± 0.005) 
caprylate (C8) 0.105 (± 0.004) 0.003 (± 0.001) 
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The enantioselectivity of the purified recombinant BCE was assayed using three different 
IPG esters (acetate, butyrate, and benzoate; Table 2), previously tested with the wild-type 
enzyme [14]. Hydrolysis of butyrate and benzoate esters occurred with high reaction rates 
and enantioselectivity (Table 2), whereas the biotransformation of acetate ester was much 
slower and less enantioselective. Biotransformation of IPG benzoate was carried out also on 
semi-preparative scale (200 mL), confirming the results obtained on small scale and proving 
the applicability of recombinant BCE as a preparative biocatalyst. 
 
Table 2. Hydrolysis of IPG derivatives by BCE. E refers to the enantiomeric ratio. 
 
R Conversion 
(%) 
e.e.substrate 
(%) 
e.e.product 
(%) 
E Time 
(h) 
CH3 46 79 (S) 93 (S) 67 24 
(CH2)2CH3 42 70 (S) 97 (S) 139 1 
Ph 49 92 (S) 96 (S) 163 0.5 
 
 
The 3D structure of BCE 
The 3D structures of ligand-free BCE and glycerol-bound BCE were solved using X-ray 
diffraction data collected on single hexagonal (space group P6322) crystal (per dataset) at 
resolutions of 1.9 Å and 1.8 Å, respectively, as described in the Experimental Procedures. 
For both datasets, one BCE monomer was present in the asymmetric unit, with an estimated 
w/v solvent content of 63.1% (Matthews coefficient of 3.3 Å3/Da). Interestingly, the 
molecular replacement package BALBES revealed that the hexagonal BCE unit cell 
(a=138.1 Å, b=138.1 Å, c= 83.3 Å) is identical to that of a eukaryotic polyphosphate 
polymerase in complex with orthophosphate (PDB entry 3G3T); this is a coincidence since 
the two enzymes are completely unrelated. Both BCE structures were refined to satisfactory 
Rfree and Rgen values (Table 3). Electron density was well-defined for almost all of the BCE 
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polypeptide, except for the last C-terminal residue and include an additional residue (in 
glycerol-bound BCE) or two (for ligand-free BCE) extra residues at the N-terminus that 
pertain to the cloning region of the pET100/D-TOPO bacterial expression vector.  
 
Table 3. Data collection, refinement and validation parameters. Data are shown for the two 
BCE datasets. aRmerge = I-(I)/  I x 100, where I is the intensity of a reflection and (I) 
is the average intensity; bRgen = Fo-Fc/Fo  x 100; cRfree was calculated from 5% 
of randomly selected data for cross-validation. Values in parentheses represent data 
belonging to highest resolution shells (Apo-BCE; 1.9-1.94 Å; glycerol-bound BCE 1.8-1.84 
Å). 
 apo-BCE BCE+glycerol 
Data collection   
Space group P6322 P6322 
   
    a, b, c (Å) 138.6  136.8  83.8 137.6  137.6  83.6 
    ,, (°) 90, 90, 90 90, 90, 90 
Resolution (Å) 40-1.9  40-1.8 
aRmerge 0.087 (0.504) 0.113 (0.598) 
I /I 26.8 (7.8) 34.9 (8.9) 
No. unique reflections 37667 (2359) 43646 (2545) 
Completeness (%) 
Redundancy 
99.8 (99.5) 
19.4 (20.4) 
99.9 (99.8) 
39.1 (37.6) 
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Refinement   
Resolution (Å) 40-1.9 40-1.8 
bRgen / cRfree 21.6/24.3 14.7/16.9 
No. atoms:   
    Protein 2456 4807 
    Glycerol - 18 
    Chloride ion - 8 
    Acetate ion - 4 
    Polyethylene glycol - 6 
    Water 50 192 
B-factors (Å2):   
    Protein 23.9 21.9 
    Glycerol - 27.5 
Chloride ion - 44.0 
Acetate ion - 38.7 
polyethylene glycol - 56.2 
    Water 30 24.1 
R.m.s. deviations:   
    Bond lengths (Å) 0.014 0.007 
    Bond angles (°) 1.258 0.856 
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Ramachandran Plot (%) 
Favored Regions 
Allowed Regions 
 
97.7 
100 
 
98.1 
100 
   
Overall 3D Fold 
The overall 3D fold of both BCE structures are essentially identical (rmsd value 0.3 Å), 
displaying the canonical / hydrolase fold shared by all members of this superfamily. The 
central -sheet comprises seven parallel strands (1 and 3-8) and one anti-parallel -strand 
(2) inserted between -strands 1 and 3, and contains eleven -helices and two 310 -helices 
(Figure 2). In contrast to activity studies, which suggest that BCE is a non-lipolytic 
carboxylesterase, BCE presents a lipase-like 3D fold deduced by the presence of an extra 
so-called 'lid domain', comprising three -helices (5, 6 and 8) that caps the entrance to 
the active site, housed in the canonical / hydrolase core (Figure 2). 
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Figure 2. Ribbon secondary structure representation of the crystal structure of apo-BCE. 
-helices (blue) and -strands (grey) and the N- and C-terminal are labeled. The lid 
domain comprising -helices 5, 6 and 8 is indicated. 
 
Accordingly, despite poor sequence conservation (25.1% sequence identity), the closest 
structural homolog (rmsd value of 1.72 Å over 154/304 C pairs) to BCE is human 
monoglyceride lipase (hMGL; PDB entry 3JWE [28]), as determined using Profunc 
(http://www.ebi.ac.uk/thornton-srv/databases/profunc/); structural conservation resides 
almost entirely in the /-hydrolase domain and the lid domains differ significantly (Figure 
3).  
48 
 
 
Figure 3. Superposition of the crystal structures of apo-BCE (blue) and inhibitor-bound 
hMGL (grey; PDB entry 3JWE, [29]). Structural variations are highlighted in shading. All 
figures were generated using Chimera [31]. 
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hMGL, like all mono- and diacylglycerol lipases studied to date, belongs to the single -
helix/loop lid lipase class [29]. If BCE were it in fact a true lipase, it would pertain to the 
large-lid class characteristic of thermophilic lipases, however in light of our activity data, it 
is likely that BCE belongs to an entirely different carboxyl esterase class all together. 
Additional structural differences between the two proteins occur at the N-terminus; hMGL 
contains an extra -helix, a shorter -strand 1, and 2 in BCE is replaced by an unstructured 
loop in hMGL (Figure 3). 
The BCE lid domain  
As previously mentioned, the absence of interfacial activation for catalysis is contradictory 
to the presence of the lipase-specific lid-domain that mediates this process. The BCE lid 
domain (residues 145-235) is particularly large, also with respect to the lids of the 21 other 
lipase members (of known structure) belonging to the large lid lipase subclass [29]. Open 
and closed lid conformations have been crystallized for several lipases, however the BCE 
lid was found in the closed conformation in all datasets collected to date, despite the absence 
or presence of glycerol bound at the active site.  
Only two lid residues (F209 and T210), housed in a 11-residue loop that connects 7 and 
8 and forms the entrance to the active site, are diversely positioned. Interestingly in apo-
BCE, lid closure does not completely block entrance to the active site, and an aperture with 
diameter of approximately 13 Å is visible (Figure 4).  
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Figure 4. Secondary structure ribbon representation of apo-BCE (grey) and glycerol-bound 
BCE (blue). Glycerol and residues F209 and T210 that are orientated diversely in the two 
structures are shown in sticks. In the glycerol-bound structure, the CZ atom of F209 is 
located 3.8Å away from the O3 atom of glycerol. In the ligand-free BCE structure the loop 
moves away from the entrance hole by 3.1 Å. The N- terminus is labeled. This figure was 
generated using Chimera [31]. 
 
This aperture may permit the diffusion of small substrates directly into the active site without 
requiring lid repositioning. In the glycerol-bound enzyme, the repositioning of F209 and 
T210 is sufficient to partially close the active site aperture. 
The presence of an active site aperture and the lack of classical lipolytic carboyxlesterase 
activity, however, does not rule out the possibility of the BCE lid switching between open 
and closed conformations during catalysis. Accordingly, molecular dynamics calculations 
were made using the online server PiSQRD (http://pisqrd.escience-lab.org) to assess BCE 
lid flexibility. Glycerol-free BCE was fragmented by computational simulations into two 
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domains that can behave as rigid units, moving independently from one another during 
protein structural fluctuations (in conditions of thermal equilibrium); the two domains 
(residues 78 to 85 (domain 1) and residues 143-227 (domain 2)) essentially represent the 
core /-hydrolase domain and the lid domain, thus highlighting the potential dynamical 
role of this region of the protein [31].  
 
The BCE active site 
The BCE active site contains a conserved catalytic triad (S114, H284 and D251) with the 
catalytic S114 being housed in the conserved GXSXG (GSHMG in BCE) motif on 5 that 
represents the nucleophilic elbow hosted in a turn that links 5 and 4. The oxyanion hole, 
which stabilizes the anionic transient tetrahedral intermediate of catalysis, is built by the 
backbone NH groups of M115 and G116 of the nucleophilic elbow, and by residues G37 
(C) and F38 (side-chain atoms). The active site-bound glycerol molecule observed in 
several of the analyzed crystals hydrogen-bonds with glycerol atom O2 and a water molecule 
that also interacts with the hydroxyl group of S114 and, via glycerol atom O1 with adjacent 
residues H113(NE2), and E285(OE2) (Figure 5).  
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Figure 5. View of the interaction between glycerol and BCE residues H113, E284 and a 
conserved water molecule (W27); hydrogen bonds are indicated by dotted lines. Interaction 
residues and catalytic triad (S114, H284, D251) residues are labeled and shown in sticks. 
  
Surface cavity analysis using CAST-P (www. http://sts.bioe.uic.edu/castp/) and the atomic 
coordinates of apo-BCE, revealed the solvent-accessible active site cavity (volume = 752.3 
Å3; area= 877.7 Å2), which comprises main-chain and/or side chain atoms of 34 residues 
(Figure 5) [31].  In glycerol-bound BCE, the size of this cavity increases (volume = 1028.6 
Å3; area= 1370.2 Å2), however solvent accessibility decreases due to slight closure of the 
aperture to the active site due to the repositioning of residues F209 and T210.  
 
In silico docking of tested IPG ester substrates 
The BCE active site is accessible by a wide tunnel terminating in a hydrophobic cavity 
located after the active residue Ser114 (Figure 6), lined by hydrophobic residues: M118, 
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F143, L173, M174, M177, F221, M225. The hydrophobic cavity is quite short (~ 10 Å) and 
thus unable to host large aliphatic chains; this explains why BCE is inactive with compounds 
longer than C10 (as previously shown in Figure 1).  
 
Figure 6. Detailed view of the apo-BCE active site, highlighting the active site tunnel 
(surface representation); the entrance to the tunnel and the hydrophobic region of the active 
site are indicated. Hydrophobic residues, the catalytic S114 and the R- and S- enantiomers 
of butyrate-IPG (sticks) that were in silico docked in the cavity are shown; 
 
Analysis by in silico docking, using p-nitrophenyl compounds with different acyl chains, 
shows that molecules from C2 to C6 can dock into the cavity in conformations compatible 
with observed enzymatic activity (Figure 7).  
 
54 
 
 
Figure 7. in silico docking of p-nitrophenyl compounds (sticks) with different acyl chains 
of variable lengths; C2 (pink), C4 (ochre) and C6 (purple) 
On the contrary, the hydrophobic cavity is too short to host compounds bigger than C6 in 
their correct conformations. It is possible that the high temperature required for optimal 
enzymatic activity induces some structural rearrangements that allow molecules up to C10 
to be processed. 
We subsequently used in silico docking to try to gain insight into the structural bases of the 
enantioselectivity of BCE. The calculated dissociation constants (Kd) for R and S 
enantiomers of different IPG esters (acetate, butyrate, and benzoate) are quite similar (Table 
4), and thus does not explain the enantioselectivity observed in the experiments.  
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Table 4. In silico docking of acetate, -butyrate and -benzoate IPG esters in the active site of 
BCE. The calculated dissociation constants (Kd) for the S- and R-enantiomers of the acetate, 
butyrate and benzoate IPG esters are shown, together with the bond length distance between 
H284 and the ether oxygen which stabilizes the tetrahedral reaction intermediate. Docking 
was carried out using Autodock 4.2 [43]. 
Compound (R) Kd  [M] 
 
(S) Kd  [M] 
 
dist. O-H284 (R) (Å) 
 
dist. O-H284 (S) (Å) 
 
Acetate-IPG 139.2 137.6 5.0 5.0 
Butyrate-IPG 41.9 43 5.0 4.3 
Benzoate-IPG 9.9 7.5 5.7 5.4 
 
To further investigate this question, the overall geometry of the chiral ligands in the active 
site was analyzed and found to differ, and can at least partially explain the different reaction 
efficiencies toward R or S-enantiomers. Among others, a parameter that is important for the 
enzymatic activity is the distance between the oxygen of the alcohol moiety of the esters and 
H284 (see Table 4 and Figure 8). This distance is crucial to stabilize the tetrahedral 
intermediate (Step 2) formed during the reaction, as previously described [33]. In IPG 
acetate, the H284 distance from the oxygen of the alcohol moiety in both R- and S-
enantiomers is the same, in agreement with the lower level of discrimination. On the 
contrary, the distance is reduced from 5.0 Å to 4.3 Å for the R- and S-enantiomers of the 
butyrate ester, respectively; this would suggest a higher efficiency in Step 2 towards S-
enantiomers (Figure 8).  
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Figure 8. Illustration of the bond distances between the oxygen and H284 in R- (yellow) and 
S-(blue) butyrate-IPG. Docking was carried out using Autodock4.2 [43]. 
Overall, these observations imply that enantioselectivity may be due to a combination of 
different features, including the different permeation of the enantiomers toward the active 
site (selected by the access tunnel).  
Circular dichroism and thermal stability studies 
The conformational stability of BCE in solution was characterized by circular dichroism 
(CD). In agreement with the crystal structure, the far-UV CD spectrum shows the typical 
features of -helix rich proteins: two minima at 220 and 208 nm, and an intersection at zero 
at about 203 nm.  Thus, the thermal stability of BCE was assessed in function of increasing 
temperature, monitoring the ellipticity at 220 nm (reporter of -helix secondary structures) 
as described in the Experimental Procedures.  
The BCE melting curve is biphasic, with a first minor conformational transition at 42°C 
(Tm1, 30% of the total transition) and a second main transition at 87°C (Tm2, 70% of the total 
transition) (Figure 9).  
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Figure 9. Thermal unfolding of BCE monitored through far-UV CD at 220 nm as described 
in the Experimental procedures. The two transitions are labeled Tm1 and Tm2, respectively. 
Inset: BCE far-UV CD spectrum; 
 
The second transition triggers a macroscopic aggregation of unfolded protein that causes 
irreversible denaturation. The reversibility of the first transition was studied by setting-up a 
multistep temperature ramp experiment. A native BCE sample was heated in a first 
temperature ramp from 20 to 60°C and then cooled down to the starting temperature of 20°C. 
The same BCE sample was heated in a second temperature ramp up to 95°C (Figure 10).  
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Figure 10.Tthe reversibility of the first conformational transition was evaluated by thermal 
unfolding of BCE, monitored through far-UV CD at 220 nm at protein concentration of 0.1 
mg/mL. Native BCE was heated from 20°C to 60°C (blue line) and then cooled down to 20°C 
The same sample was heated up to 95°C (red line). The two transitions are labeled Tm1 and 
Tm2, respectively. In this experiment, Tm2 occurs at higher temperature due to the lower 
protein concentration. 
In the second temperature ramp the first minor melting is no longer visible, whereas the 
second main transition is perfectly conserved, proving that the two transition are irreversible 
and, apparently, independent. 
Although the structural regions involved in the first transition have not been identified, to 
gain better insight into the nature of these conformational transitions we carried-out activity 
assays on BCE, with and without heat-treatment at 60°C. Interestingly, also the heat-treated 
protein was catalytically competent, although a 90% decrease in activity was observed. 
According to the molecular dynamics calculations that divide the BCE structure into two 
independent domains (the core /-hydrolase domain and the lid domain) we hypothesize 
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that the lid domain may be responsible for the first unfolding event, affecting the catalytic 
function of BCE only marginally. This hypothesis is also in good agreement with a 
“quantitative” analysis of the unfolding trace: the signal lost in the first transition is about 
30%, thus compatible with loss of the three -helices of the lid relative to a total of the 
eleven -helices of the whole structure. Lid unfolding would have an effect on binding to 
the hydrophobic tail of the substrate, whereas binding to the oxyanion hole would be 
essentially unaffected. 
Protein thermostability can be attributed to a number of other structural features such as the 
presence of disulfide bonds and intra-helical salt bridges [33]. BCE1 does not contain any 
disulfide bonds and in fact, only contains one non-conserved cysteine residue (C137). Using 
the ESPRI web server (http://bioinformatica.isa.cnr.it/ESBRI/introduction.html), 21 salt 
bridges (2.4-3.9 Å) were found in BCE, none of which are present within the lid domain, 
although two are formed between lid residue (D79) and residues R14(NZ) (3.2 Å) and 
R216(NH2) (3.1 Å (OD2) and 3.3 Å (OD1)) [34, 35]. These analyses also corroborate the 
theory that the /-hydrolase core is stable to a greater extent than the lid domain, supporting 
both the MD and CD studies and reinforces the likelihood that lid unfolding is responsible 
for the first unfolding transition.  
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Discussion  
Carboxylesterases are ubiquitous enzymes that catalyze the cleavage and/or formation of 
carboxyl ester bonds. Their division into lipolytic (lipases) and non-lipolytic esterases is 
based on experimental data and theoretical hypothesis, and is often quite uncertain. All 
carboxylesterases share the so-called α/β hydrolase fold, where five (or more) strands in a 
central β-sheet forming the protein core are connected by α-helices; this superfamily is one 
of the largest families of structurally-related enzymes. Despite such elevated structural 
conservation, /-hydrolase members catalyze a wide variety of chemical transformations, 
and thus are extensively used in industrial processes. Lipases are characterized by the 
presence of a mobile subdomain (lid), which caps and shields substrate entry to the active 
site. The closed-lid conformation is supposed to be preponderant in water, where most 
lipases are poorly active, whereas interactions with hydrophobic compounds (substrates, 
organic solvents) are thought to prompt a conformational change of the lid making it 
accessible to the substrates (open-lid). The overall phenomenon is generally referred as 
“interfacial activation” [36]. 
Due to their advantageous biochemical properties, such as high chemo-, regio- and stereo-
selectivity and thermostability, microbial carboxylesterases have numerous industrial 
applications in a wide range of sectors [4-6]. Kinetic resolution of racemic esters of chiral 
alcohols via their enantioselective hydrolysis is among the most studied application. 
Optically pure (S)-1,2-O-isopropylideneglycerol (IPG) is a key intermediate for the 
preparation of β-blockers, leukotrienes, phospholipids, and prostaglandins [24]. Hydrolysis 
of racemic IPG esters has been explored using different carboxylesterases aiming at optically 
pure (S)-IPG; commercially available lipases are generally poorly active or scarcely 
enantioselective towards racemic IPG esters [25]. We previously found that BCE, a 
carboxylesterase from B. coagulans, carried out the kinetic resolution of different racemic 
IPG esters yielding (S)-IPG with high enantioselectivity [14].  
To gain insight into the structure-function properties of BCE that may account for such 
enantioselectivity for IPG esters, we carried out the recombinant production, functional 
characterization and 3D structure determination of BCE (ligand-free and glycerol-bound). 
Recombinant BCE successfully catalyzed the enantioselective hydrolysis of different IPG 
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esters in providing optically pure (S)-IPG with good reaction rates and excellent 
enantiomeric ratios; the best results being obtained with butyrate (C4) and benzoate (C6) 
IPG esters. Activity however diminished by 10% for C8 chains and by 90% for C10 chains 
and was completely abolished for C12 and C16 chains. In line with these data, structure 
analyses show that the active site cavity may only accommodate substrates with aliphatic 
carbon chain lengths shorter or equal to C6. Given the activity of BCE at elevated reaction 
temperatures that reach as high as 65°C, it is possible that at high temperatures, a 
conformational change is induced, allowing expansion of the active site and permitting the 
hydrolysis of slightly longer substrates. In fact, CD thermal stability studies show that there 
are two unfolding events, with the former occurring at a TM of 45°C. We hypothesize that 
this event reflects the unfolding of the lid domain, as indicated by MD studies and structural 
observations made that underline the presence of 21 stabilizing salt bridges in the /-
hydrolase core and none in the lid domain. Given that hydrophobic residues of the lid domain 
contribute to forming the hydrophobic cavity that binds the aliphatic carbon tail of ester 
substrates, it is unsurprising that substrate specificity may be altered at higher reaction 
temperatures.  
Poor activity towards long-chain esters, together with high enantioselectivity towards IPG 
esters are typical features of non-lipolytic carboxylesterases. Moreover, benzoate esters, 
which are easily hydrolyzed by BCE, are not preferred substrates for lipases (with the 
exception of the very versatile Candida antartica Lipase B-CALB) [37]. Such functional 
findings are in sharp contrast to our structural studies that highlight the presence of a lipase-
typical lid domain, in addition to the canonical /-hydrolase fold. Given the role of this 
domain for catalysis in a process termed interfacial activation, where optimal reaction rates 
are observed at the hydrophobic-water interface, we carried out experiments in the presence 
of a triglyceride layer reproduced by the addition of tributyrin. In agreement with our activity 
studies but in contrast to the presence of this lipase-specific domain, interfacial activation 
was not observed. The lack of interfacial activation and the fact that BCE was able to convert 
the (small) substrates used in this study in water with conventional kinetics, was also implied 
by the lack of lid positioning in the ligand-free and glycerol-bound structures. Interestingly, 
despite the observed 'closed' lid state of ligand-free BCE, access to the substrate-binding site 
was not completely blocked and a 13 Å mouth-opening to the active site tunnel was observed 
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that could easily permit the diffusion of IPG esters, as illustrated by our structural analyses. 
Despite non-lipase functions, we cannot rule out the lid domain switching between 'open' 
and 'closed' conformations; in silico simulations and computational analyses carried out on 
the BCE structure, focusing on protein flexibility and rigid body movements, detected the 
lid domain as a mobile entity. 
In lipases, the size and structural arrangement of the lid domain varies considerably and 
recent attempts have been made to classify lipase sub-groups according to the size and 
conformation of the lid [30]. Based on 44 distinct lipase structures, three sub-groups were 
devised: i) lipases that lack a lid, ii) lipases that contain a lid formed by a single loop or -
helix, and iii) lipases that contain lids comprised of two or more -helices. A link between 
optimum reaction temperature and lid organization was observed; large lids are correlated 
to catalysis at higher reaction temperatures [30]. Based on this classification, and the, were 
BCE, with its particularly large BCE lid (approx. 90 residues), would pertain to the third 
class of large lid lipases that exhibit thermostable properties[30]. This is in agreement with 
our findings, demonstrating that BCE remains active at high reaction temperatures.   
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Conclusion 
Our studies revealed that BCE is an atypical carboxylesterase characterized by non-lipolytic 
functionalities in contrast to a lipase-like 3D fold. With regards to the enantioselective 
hydrolysis of short-chain and benzoate esters of IPG, with a preference for (S)-IPG esters, 
in silico docking studies on the BCE structure suggest that a reduced distance between the 
catalytic histidine residue (H284) side chain that stabilizes the tetrahedral reaction 
intermediate during catalysis and the oxygen atom of the ester alcohol group, may play a 
role, however further studies are required. Thanks to the here-reported crystal structures, in 
silico docking may be used to identify inhibitors that may be used in co-crystallization 
studies to reveal the active residues that govern this specificity. Our results may pave the 
way for rational engineering strategies aimed at the construction of new variants with wider 
substrate specificities, and thus suited for different applications as stereoselective 
biocatalysts 
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Abstract 
The stereoselective desymmetrisation of achiral 2-alkyl-1,3-diols is performed by oxidation 
of one of the two enantiotopic primary alcohol moieties by means of Acetobacter aceti MIM 
2000/28 to afford the corresponding chiral 2-hydroxymethyl alkanoic acids (up to 94% ee). 
The procedure, carried out in aqueous medium under mild conditions of pH, temperature 
and pressure, contributes to enlarge the portfolio of enzymatic oxidations available to 
organic chemists for the development of sustainable manufacturing processes. 
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Introduction  
The stereoselective desymmetrisation of achiral and meso substrates is a highly effective 
procedure for the preparation of enantiomerically enriched compounds. The technique 
consists of the chemical modification of a molecule to remove one or more symmetry 
elements precluding chirality. [1] Typically, it is achieved by using a chiral reagent or catalyst 
to distinguish between two enantiotopic groups of the starting substrate and selectively 
promote the chemical transformation of only one of them. The huge potential of this 
procedure of asymmetric activation has been widely exploited for a large array of structurally 
diverse substrates.[2] In the last decade, enzymes have received great attention for the 
optimisation of desymmetrisation procedures: [3] for example, biocatalysed ester hydrolysis 
and transesterifications have been successfully applied to prepare enantiomerically enriched 
compounds starting from achiral diesters and diols. Relevant examples involving chiral 
active pharmaceutical ingredients (APIs) have been recently reported.[4] Among biocatalysed 
reactions, the oxidation of alcohols and sugars mediated by acetic acid bacteria (e.g., 
Acetobacter sp., Acidiphilium sp., Gluconobacter sp.) is a very powerful tool for the 
development of sustainable synthetic transformations.[5] This remarkable activity is powered 
by a peculiar respiratory chain system: [6] in acetic acid bacteria, many types of membrane-
bound dehydrogenases, located on the periplasmatic surface of the cytoplasmatic membrane, 
reduce ubiquinone with concomitant substrate oxidation, then the reduced form of 
ubiquinone is re-oxidized by the terminal ubiquinol oxidases. Substrate oxidation occurs 
according to a two-step sequence, first involving the conversion of the primary alcohol into 
aldehyde by a pyrroquinoline quinone-dependent alcohol dehydrogenase (PPQ-ADH) and 
then the final transformation of the aldehyde intermediate into carboxylic acid by an 
aldehyde dehydrogenase. The reaction shows excellent chemo-, regio- and stereoselectivity, 
and it is carried out under mild conditions of temperature, pressure and pH, in non-
problematic solvents, at high turnover rates.[7] Moreover, acetic acid bacteria are acidophilic 
microorganisms that thrive in acidic environments at pH values below 4.0, hence they are 
particularly naturally fit to accumulate high concentrations of carboxylic acids.[8]  
All these features make this oxidation suitable for the selective modification of one 
enantiotopic primary alcohol moiety over another. Nonetheless, to our knowledge, the 
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potential of this enzymatic oxidative procedure for the desymmetrisation of achiral diols has 
been scarcely investigated. For 1,5-diols, only the conversion of the 3-methyl-substituted 
derivative into the corresponding enantiomerically enriched d-lactone was investigated, 
either by using Gluconobacter roseus[9] or by a two-step oxidation mediated by horse liver 
alcohol dehydrogenase.[10] The oxidative desymmetrisations of 1,3-diols reported so far are 
limited to those of 2-methyl and 2-butyl derivatives catalysed by acetic acid bacteria. The 
microbial oxidation of 2-methyl-1,3-propanediol leading to (R)-3-hydroxy-2-
methylpropionic acid (an important building block for the synthesis of the ACE inhibitor 
captopril) was described in 2003, reporting 97% enantiomeric excess and 100% molar 
conversion of 5 gL -1 within 2 h, by using Acetobacter pasteurianus DSM 8937.[11] More 
recently, A. pasteurianus IAM 12073 was found to produce the (S)-enantiomer of 2-
(hydroxymethyl)hexanoic acid from 2-butyl-1,3-diol with 89% enantiomeric excess and 
82% conversion after 24 h of incubation.[12] The few available sets of data on the use of 
acetic acid bacteria in desymmetrisation reactions prompted us to investigate more 
systematically their synthetic potential for the conversion of achiral 1,3-diols into chiral 
hydroxyalkanoic acids according to this procedure to enlarge the portfolio of enzymatic 
reactions available to organic chemists for the development of sustainable manufacturing 
processes. The results of our research are herein reported. 
 
 
 
 
 
 
 
 
73 
 
Experimental Section 
General methods 
1H and 13C NMR spectra were recorded with a 400 or 500 MHz spectrometer in 
CDCl3solution at room temperature. The chemical shift scale was based on internal tetra 
methylsilane. 
GC/MS analyses were performed by using a HP-5MS column (30 m×0.25 mm×0.25 μm, 
Agilent). The following temperature program was employed: 60 °C (1 
min)/6 °C min−1/150 °C (1 min)/12 °C min−1/280 °C (5 min). 
Chiral GC analysis was performed on a Chirasil-DEX-CB (25 m×0.25 mm×0.25 μm, 
Chrompack) column or on a DAcTBSil BetaCDX column (25 m×0.25 mm×0.25 μm, 
Mega), installed on a gas chromatograph equipped with FID (carrier gas H2, constant flow 
3.7 mL min−1, tinjector=250 °C, tdetector=250 °C). Chiral HPLC analysis was performed on a 
Chiralcel OD column (4.6 mm×250 mm, Daicel) installed on an HPLC instrument with UV 
detector (λ=220 nm). 
TLC analysis was performed on Merck Kieselgel 60 F254 plates. All the chromatographic 
separations were carried out on silica gel columns. 
Microorganisms, growth and biotransformation conditions 
Acetobacter aceti MIM 2000/28 and Asaia bogorensis SF2.1 from the MIM collection 
(Microbiologia Industriale Milano), and Gluconobacter oxydans DSM 50049 (Deutsche 
Sammlung von Mikroorganismen) were employed in the preliminary screening. All strains 
were routinely maintained on GYC slants (glucose 50 g L−1, yeast extract 10 g L−1, 
CaCO330 g L
−1, agar 15 g L−1, pH 6.3) at 28 °C. Strains, grown on GYC slants for 24 h at 
28 °C, were inoculated into 100 mL baffled Erlenmeyer flasks containing 20 mL of liquid 
GLY medium (glycerol 25 g L−1, yeast extract 10 g L−1, pH 5, distilled water). After 24 h at 
28 °C, 150 rpm, the entire culture was used to inoculate 2 L baffled Erlenmeyer flasks 
containing 200 mL of GLY medium and incubated under the same conditions. A. aceti MIM 
2000/28 was selected for the development of the oxidative desymmetrisation reactions. 
74 
 
The biotransformations were performed directly inside the culture flasks according to the 
following procedure. The suitable neat diol 1 a–i (200 mg) was added to the cultural broth 
(200 mL) and the flask was shaken at 150 rpm at 30 °C. After 72 h, the reaction mixture was 
centrifuged to remove the bacterial cells, the supernatant was brought to pH 2.0 with aqueous 
HCl and extracted with Et2O. The combined organic phases were dried over anhydrous 
Na2SO4. The residue was purified by column chromatography on a silica gel column, eluting 
with n-hexane and increasing amounts of ethyl acetate to obtain the corresponding hydroxy 
acid. 
Characterisation of the products obtained by oxidative desymmetrisation of diols 1 a–
i 
(R)-(Hydroxymethyl)propanoic acid ((R)-2 a) 
From 1 a (0.200 g, 2.22 mmol), derivative (R)-(−)-2 a was obtained (0.231 g, 
89 %): ee=94 % (determined from the corresponding methyl ester) [α]D=−11.3 (c=1.00, 
EtOH), ref. [28]; 1H NMR (CDCl3, 300 MHz):[29] δ=5.70 (1 H, bs), 3.75 (1 H, d, J=6.0 
MHz), 2.74 (1 H, m), 2.10 (1 H, s,), 1.22 ppm (3 H, d, J=7.4 MHz); 13C NMR (CDCl3, 75 
MHz): 180.1, 64.0, 41.6, 13.2 ppm. 
(R)-2-(Hydroxymethyl)butanoic acid ((R)-2 b) 
From 1 b (0.200 g, 1.92 mmol), derivative (R)-(−)-2 b was obtained (0.057 g, 
25 %): ee=54 % (determined from the corresponding methyl ester) [α]D=−2.8 (c=0.50, 
CHCl3); 
1H NMR (CDCl3, 400 MHz):[30] δ=3.90–3.70 (2 H, m, CH2OH), 2.56 (1 H, 
m, CHCOOH), 1.80–1.55 (2 H, m, CHCH2), 1.00 ppm (3 H, t, J=7.6 Hz, CH2CH3); 
13C 
NMR (CDCl3, 100.6 MHz):[30] δ=180.4, 62.7, 49.0, 21.6, 11.8 ppm. 
Methyl (R)-2-(hydroxymethyl)butanoate ((R)-5 b) 
Compound (R)-2 b (0.050 g, 0.424 mmol) was heated at reflux in MeOH (4 mL) in the 
presence of a catalytic quantity of H2SO4 to afford, after the usual work-up, the 
corresponding methyl ester (+)-(R)-5 b (0.053 g, 95 %): ee=54 % (by chiral HPLC of the 
3,5-dinitrobenzoate derivative) [α]D=+2.4 (c=1.1, CHCl3), ref. [31]; for (R)-5 b ee=88 % 
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[α]D=+4.1 (c=1.0, CHCl3); 1H NMR (CDCl3, 400 MHz):[32] δ=3.84–3.66 (5 H, m+s, 
CH2OH+OCH3), 2.52 (1 H, m, CHCOOCH3), 1.75–1.50 (2 H, m, CH2CH3), 0.95 ppm (3 H, 
t, J=7.4 Hz, CH2CH3); 
13C NMR (CDCl3, 100.6 MHz): δ=175.0, 63.0, 51.8, 49.1, 21.8, 
11.8 ppm; GC/MS (EI): tR=6.50 min: m/z (%)=114 (M
+−18, 8), 102 (50), 87 (100). 
The absolute configuration was confirmed by comparing the HPLC analysis of the 3,5-
dinitrobenzoate derivative 7 b prepared from (+)-(R)-5 b with a sample of the 3,5-
dinitrobenzoate derivative of (S)-5 b prepared by baker's yeast reduction of ethyl 2-
formylbutanoate 6 b,[22] followed by transesterification with MeOH and a catalytic 
quantity of H2SO4. 
Chiral HPLC: Chiralcel OD (n-hexane/iPrOH 9:1, 0.6 mL min−1), tR (R)-7 b=51.30 
min, tR(S)-7 b=61.32 min. 
1 -Methylenebutanoic acid (3 b) and 2-methylbutanoic acid (4 b) 
From 1 b (0.200 g, 1.92 mmol), besides derivative (R)-2 b (25 %), a 1:1.5 (1H NMR) 
mixture of 3 b and 4 b (0.097 g) was isolated: 1H NMR (CDCl3, 400 MHz), signals 
of 3 b:[33] δ=6.27 (1 H, br s, CHH=C), 5.65 (1 H, br s, CHH=C), 2.34 (1 H, q, J=7.2 Hz, 
CH2C=), 1.10 ppm (3 H, t, J=7.2 Hz, CH2CH3); signals of 4:[
34] δ=2.42 (1 H, m, 
CHCOOH), 1.60 (2 H, m, CH2CH), 1.18 (3 H, t, J=6.9 Hz, CHCH3), 0.89 ppm (3 H, 
t, J=7.4 Hz, CH2CH3); GC/MS (EI): 3 btR=5.46, m/z (%)=100 (M+, 78), 85 (52), 55 
(100); 4 b tR=4.99: m/z (%)=87 (M+−15, 25), 74 (100), 57 (55). 
(R)-2-(Hydroxymethyl)pentanoic acid ((R)-2 c) 
From 1 c (0.200 g, 1.69 mmol), derivative (R)-2 c was obtained (0.114 g, 51 %): ee=68 % 
(determined from the corresponding methyl ester) [α]D=−2.3 (c=2.2, CHCl3), ref. [35]; for 
(R)-2 c ee=92 % [α]D=−3.0 (c=10, CHCl3); 1H NMR (CDCl3, 400 MHz):[35] δ=3.85–3.70 
(2 H, m, CH2OH), 2.62 (1 H, m, CHCOOH), 1.70–1.30 (4 H, m, CHCH2CH2), 0.93 ppm 
(3 H, t, J=7.6 Hz, CH2CH3); 
13C NMR (CDCl3, 100.6 MHz):[35] δ=180.0, 63.2, 47.5, 
30.5, 20.6, 14.1 ppm. 
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Methyl (R)-2-(hydroxymethyl)pentanoate ((R)-5 c) 
Compound (R)-2 c (0.090 g, 0.681 mmol) was heated at reflux in MeOH (4 mL) in the 
presence of a catalytic quantity of H2SO4 to afford, after the usual work-up, the 
corresponding methyl ester (R)-5 c (0.096 g, 97 %): ee=68 % (by chiral HPLC of the 3,5-
dinitrobenzoate derivative) [α]D=−2.4 (c=1.5, CHCl3); 1H NMR (CDCl3, 400 
MHz):[19] δ=3.80–3.70 (5 H, m+s, CH2OH+OCH3), 2.60 (1 H, m, CHCOOCH3), 1.70–
1.45 (2 H, m, CHCH2CH2), 1.40–1.30 (2 H, m, CHCH2CH2), 0.95 ppm (3 H, t, J=7.4 Hz, 
CH2CH3); 
13C NMR (CDCl3, 100.6 MHz): δ=175.8, 63.2, 51.6, 47.2, 30.6, 20.4, 13.9 ppm; 
GC/MS (EI): tR=8.53 min: m/z (%)=128 (M
+−18, 1), 116 (20), 104 (28), 87 (100). 
The absolute configuration was confirmed by comparing the HPLC analysis of the 3,5-
dinitrobenzoate derivative 7 c prepared from (R)-5 c with a sample the of 3,5-
dinitrobenzoate derivative of (S)-5 c prepared by baker's yeast reduction of ethyl 2-
formylpentanoate 6 c,[22] followed by transesterification with MeOH and a catalytic 
quantity of H2SO4. 
Chiral HPLC: Chiralcel OD (n-hexane/iPrOH 9:1, 0.6 mL min−1), tR (S)-7 c=46.9 
min, tR(R)-7 c=57.2 min. 
2 -Methylenepentanoic acid (3 c) and 2-methylpentanoic acid (4 c) 
From 1 c (0.200 g, 1.69 mmol), besides derivative (R)-2 c (51 %), a 4:1 (1H NMR) mixture 
of 3 c and 4 c (0.039 g) was isolated. Only the signals[36] of 3 c are herein reported: 1H 
NMR (CDCl3, 400 MHz): δ=6.27 (1 H, br s, CHH=C), 5.63 (1 H, br s, CHH=C), 2.28 (1 H, 
t, J=7.5 Hz, CH2C=C), 1.60–1.40 (2 H, m, CH2CH3), 0.90 ppm (3 H, t, J=7.2 Hz, 
CH2CH3); GC/MS (EI): 3 c tR=6.80: m/z (%)=114 (M+, 25), 99 (31), 86 (42), 69 
(100); 4 c tR=6.10: m/z (%)=115 (M+−1, 1), 101 (5), 87 (15), 74 (100). 
(S)-2-(Hydroxymethyl)pent-4-enoic acid ((S)-2 d) 
From 1 d (0.200 g, 1.72 mmol), derivative (S)-2 d was obtained (0.143 g, 64 %): ee=50 % 
(determined by conversion into (S)-7 c) [α]D=−0.4 (c=2.4, CHCl3); 1H NMR (CDCl3, 400 
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MHz): δ=5.84–5.72 (1 H, m, CH=C), 5.16–5.00 (2 H, m, CH2=C), 3.80 (2 H, d, J=6.1 Hz, 
CH2OH), 2.70 (1 H, quintuplet, J=6.2 Hz, CHCOOH), 2.52–2.40 (1 H, m, CHHC=C), 
2.38–2.26 ppm (1 H, m, CHHC=C); 13C NMR (CDCl3, 100.6 MHz): δ=179.2, 134.6, 117.6, 
62.5, 47.1, 32.5 ppm; GC/MS (EI) as methyl ester: tR=8.11 min: m/z (%)=112 (M
+−32, 12), 
97 (68), 67 (100). 
3 -Methylpent-4-enoic acid (4 d) 
Compound 4 d was detected by GC/MS analysis of the crude residue, obtained after the 
work-up of the reaction of diol 1 d: GC/MS (EI): 4 d tR=5.50 min: m/z (%)=114 (14), 99 
(21), 69 (82), 41 (100). 
(S)-2-(Hydroxymethyl)hexanoic acid ((S)-2 e) 
From 1 e (0.200 g, 1.52 mmol), derivative (S)-2 e was obtained (0.157 g, 71 %): ee=81 % 
(chiral GC analysis as a methyl ester after diazomethane treatment) [α]D=−5.1 (c=0.75, 
CH3OH), ref. [37]; for (R)-2 e ee=99 % [α]D=+6.5 (c=1.0, CH3OH); 1H NMR (CDCl3, 400 
MHz):[37] δ=3.85–3.75 (2 H, m, CH2OH), 2.61 (1 H, quint., J=5.9 Hz, CHCOOH), 1.75–
1.65 (1 H, m, CHCHHCH2), 1.60–1.45 (1 H, m, CHCHHCH2), 1.40–1.28 (4 H, m, 
CHCH2(CH2)2), 0.91 ppm (3 H, t, J=6.4 Hz, CH2CH3); 
13C NMR (CDCl3, 100.6 
MHz): δ=180.1, 63.2, 47.9, 29.8, 28.4, 22.7, 14.0 ppm; GC/MS (EI) as methyl 
ester: tR=10.81 min: m/z (%)=142 (M
+−18, 1), 130 (20), 104 (54), 87 (100). 
Chiral GC: DAcTBSil BetaCDX, 60 °C/0.8 °C min−1/90 °C/30 °C min−1/220 °C (2 
min), tR (R)-2 e=29.9 min, tR (S)-2 e=30.6 min. 
4 -Methylhexanoic acid (4 e) 
Compound 4 e was detected as a methyl ester by GC/MS analysis of the crude residue, 
obtained after the work-up of the reaction of diol 1 e: GC/MS (EI): 4 e tR=5.97 
min: m/z(%)=129 (M+−15, 2), 113, (8), 101 (25), 88 (100). 
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 (S)-2-(Hydroxymethyl)heptanoic acid ((S)-2 f) 
From 1 f (0.200 g, 1.37 mmol), derivative (S)-(−)-2 f was obtained (0.186 g, 
85 %): ee=92 % (determined from the corresponding methyl ester) [α]D=−2.1 (c=2.3, 
CHCl3); 1H NMR (CDCl3, 400 MHz):[38] δ=3.85–3.70 (2 H, m, CH2OH), 2.59 (1 H, 
quint, J=5.9 Hz, CHCOOH), 1.70–1.57 (1 H, m, CHCHHCH2), 1.55–1.42 (1 H, m, 
CHCHHCH2), 1.40–1.20 (6 H, m, CHCH2(CH2)3), 0.88 ppm (3 H, t, J=6.5 Hz, 
CH2CH3); 13C NMR (CDCl3, 100.6 MHz): δ=179.6, 63.2, 47.9, 31.8, 28.4, 26.9, 22.5, 
14.0 ppm. 
Methyl (S)-2-(hydroxymethyl)heptanoate ((S)-5 f) 
Compound (S)-(−)-2 f (0.120 g, 0.750 mmol) was heated at reflux in MeOH (4 mL) in the 
presence of a catalytic quantity of H2SO4 to afford, after the usual work-up, the 
corresponding methyl ester (−)-5 f (0.125 g, 96 %): ee=92 % (chiral HPLC of the 3,5-
dinitrobenzoate derivative) [α]D=−8.9 (c=1.1, CHCl3); 1H NMR (CDCl3, 400 
MHz):[38] δ=3.80–3.65 (5 H, m+s, CH2OH+COOCH3), 2.58 (1 H, m, CHCOOH), 1.70–
1.57 (1 H, m, CHCHHCH2), 1.56–1.47 (1 H, m, CHCHHCH2), 1.40–1.20 (6 H, m, 
CHCH2(CH2)3), 0.88 ppm (3 H, t, J=6.4 Hz, CH2CH3); 
13C NMR (CDCl3, 100.6 
MHz): δ=176.0, 63.3, 51.8, 47.7, 31.8, 28.6, 27.0, 22.5, 14.0 ppm; GC/MS (EI): tR=13.83 
min: m/z (%)=156 (M+−18, 1), 144 (25), 104 (83), 87 (100). 
Chiral HPLC: Chiralcel OD (n-hexane/iPrOH 9:1, 0.6 mL min−1), tR (R)-7 f=45.1 
min, tR(S)-7 f=57.0 min. 
(R)-2-Methylheptan-1-ol ((R)-8) 
Compound (−)-5 f (0.130 g, 0.747 mmol) was treated with mesyl chloride (0.102 g, 0.896 
mmol) and Et3N (0.113 g, 0.112 mmol) in CH2Cl2 (5 mL). After the usual work-up, the 
mesylated derivative was isolated and submitted without any further purification to 
LiAlH4(0.042 g, 1.12 mol) reduction in THF (10 mL) heated at reflux to afford, after the 
usual work-up, compound (R)-(+)-8 (0.073 g, 75 %): ee=88 % (chiral GC of the acetyl 
derivative) [α]D=+11.5 (c=1.4, CHCl3), ref. [39]; for (S)-8 ee=98 % [α]D=−13.1 (c=1.15, 
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CHCl3); 
1H NMR (CDCl3, 400 MHz):[40] δ=3.50 (1 H, dd, J=10.4, 5.7 Hz, CHHOH), 3.43 
(1 H, dd, J=10.4, 6.5 Hz, CHHOH), 1.61 (1 H, m, CHCH3), 1.40–1.15 (8 H, m, CH(CH2)4), 
0.95–0.85 ppm (6 H, d+t, CHCH3+CH2CH3); 
13C NMR (CDCl3, 100.6 MHz): 68.5, 35.9, 
33.3, 32.3, 30.5, 26.8, 22.8, 16.7, 14.2 ppm; GC/MS (EI): tR=9.2 min (as acetyl 
derivative): m/z (%)=112 (M+−60, 10), 97 (5), 84 (15), 56 (60), 43 (100). 
Chiral GC: Chirasil-DEX-CB, 60 °C/0.8 °C min−1/90 °C/90 °C min−1/180 °C, tR (S)-
8=16.48 min, tR (R)-8=16.6 min (as acetyl derivative). 
(R)-2-Benzyl-3-hydroxypropanoic acid ((R)-2 i) 
From 1 i (0.200 g, 1.20 mmol), derivative (R)-2 i was obtained (0.104 g, 48 %): ee=92 % 
(determined from the corresponding methyl ester) [α]D=+14.2 (c=2.1, CHCl3), ref. [41]; for 
(R)-2 i ee=86.4 % [α]D=+13.5 (c=3.1, CHCl3); 1H NMR (CDCl3, 400 MHz):[41] δ=7.35–
7.15 (5 H, m, ArH), 3.76 (2 H, m, CH2OH), 3.12–3.04 (1 H, m, CHCOOCH3), 2.94–2.84 
ppm (2 H, m, CH2Ph); 
13C NMR (CDCl3, 100.6 MHz):[41] δ=178.9, 138.4, 129.1, 128.8, 
126.8, 62.0, 48.8, 34.2 ppm; GC/MS (EI): tR=19.11 min (as methyl ester): m/z (%)=194 
(M+, 2), 176 (50) 117 (75), 91 (100). 
Methyl (R)-2-benzyl-3-hydroxypropanoate ((R)-5 i) 
Compound (R)-2 i (0.090 g, 0.500 mol) was heated at reflux in MeOH (4 mL) in the 
presence of a catalytic quantity of H2SO4 to afford, after the usual work-up, the 
corresponding methyl ester (R)-5 i (0.087 g, 90 %): ee=92 % [α]D=+23.9 (c=1.1, CHCl3), 
ref. [42]; for (S)-5 i ee=96 % [α]D=−25.1 (c=0.56, CHCl3); 1H NMR (CDCl3, 400 
MHz):[42] δ=7.32–7.16 (5 H, m, ArH), 3.73 (2 H, m, CH2OH), 3.69 (3 H, s, OCH3), 3.07–
2.98 (1 H, m, CHCOOCH3), 2.92–2.80 ppm (2 H, m, CH2Ph); 
13C NMR (CDCl3, 100.6 
MHz):[42] δ=175.1, 138.7, 129.1, 128.7, 126.7, 62.4, 51.9, 39.6, 34.6 ppm; GC/MS 
(EI): tR=19.11 min: m/z(%)=194 (M
+, 2), 176 (50) 117 (75), 91 (100). 
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Chiral GC: DAcTBSil BetaCDX, 70 °C/10 °C min−1/110 °C (60 min)/50 °C min−1/220 °C 
(2 min), (R)-5 i tR=51.80 min, (S)-5 i tR=53.9 min. 
(R)-2-Methyl-3-phenylpropionic acid ((R)-4 i) 
From 1i (0.200 g, 1.20 mmol), besides derivative (R)-2 i (48 %), compound (R)-4 i (0.020 
g, 10 %) was isolated: ee=58 % (by chiral GC of the methyl ester) [α]D=−17.8 (c=1.2, 
CHCl3), ref. [43]; for (S)-4 i ee=99.2 % [α]D=+30.2 (c=0.82, CHCl3); 1H NMR (CDCl3, 
400 MHz):[43] δ=7.35–7.15 (5 H, m, ArH), 3.08 (1 H, dd, J=13.4, 6.3 Hz, PhCHH), 2.77 
(1 H, m, CHCOOH), 2.67 (1 H, dd, J=13.4, 8.0 Hz, PhCHH), 1.18 ppm (3 H, d, J=6.9 Hz, 
CH3CH); 
13C NMR (CDCl3, 100.6 MHz):[44] δ=182.4, 139.2, 129.1, 128.6, 126.7, 41.3, 
39.5, 16.6 ppm; GC/MS (EI): tR=16.29 min: m/z (%)=164 (M
+, 23), 118 (7), 91 (100). 
Chiral GC: Chirasil DEX CB, 65 °C/0.5 °C min−1/85 °C/50 °C min−1/180 °C (2 min), (R)-
4 itR=37.9 min, (S)-4 i tR=38.8 min. 
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Results and Discussion 
2-Alkyl- and 2-aryl-1,3-diols 1 a–i reported in Scheme 1 were selected as starting achiral 
substrates, not only to investigate in a systematic way the effect of the substitution at position 
2, but also because of the relevance of the corresponding oxidation products, that is, chiral 
1-(hydroxymethyl)alkanoic acids 2, in the synthesis of chiral APIs. As a matter of fact, most 
of the known enantioselective syntheses of the resulting hydroxy acids 2 are described in 
patents filed by pharmaceutical companies, as we will discuss in the following paragraphs. 
 
Scheme 1. Microbial desymmetrisation of achiral 1,3-diols. 
Compounds 1 a, h and i were commercially available, whereas the remaining diols were 
prepared by LiAlH4 treatment of the corresponding 2-substituted malonates, obtained by 
monoalkylation of dimethyl malonate with the suitable alkyl bromide (Scheme 2). 
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Scheme 2. Synthesis of 1,3-diol substrates 1a-d. i) NaH, THF, RBr; ii) LiAlH4, THF, reflux. 
2-(Hydroxymethyl)alkanoic acids 2 a and e have been already obtained by microbial 
oxidation with acetic acid bacteria of the corresponding diols,[11, 12] thus these 
biotransformations were chosen as the benchmark for testing the activity of the strains used 
in this work. 
Preliminary investigations were performed with three different acetic acid bacteria, 
namely Acetobacter aceti MIM 2000/28,[7] Asaia bogorensis SF2.1[13] 
and Gluconobacter oxydans DSM 2343,[14] known for their oxidative activity on 
structurally different primary alcohols. Efficient oxidation was achieved only with A. aceti, 
whereas the other two strains showed either scarce or no activity towards substrates 1 a–i. 
Diols 1 a–i were submitted to A. aceti treatment in water at 32 °C with a starting substrate 
concentration of 1 g L−1. The presence of either DMSO or ethanol as a co-solvent (at a 
concentration as low as 1 % v/v) was found to inhibit the complete conversion of the diol; 
thus, the oxidative desymmetrisations were carried out by adding the neat diols to the buffer, 
taking advantage of their partial solubility in aqueous medium. The product distributions and 
the enantiomeric excess values of the final compounds are reported in Table 1. 
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Table 1. Data of the biocatalysed desymmetrisation of diols 1 with A. aceti. 
Substrate (1) (2) (3) (4) 
 ca            
(%) 
ca 
(%) 
Yield[b] 
(%) 
eeb             
(%) 
ca                      
(%) 
ca 
(%) 
eeb 
(%) 
1a, R = Me <1 95 89 94 (R) <1 <1 n.d 
1b, R = Et <1 33 25 54 (R) 20 47 n.d 
1c, R = n-Pr 18 62 51 68 (R) 17 3 n.d. 
1d, R = allyl 12 85 64 50 (S) <1 3 n.d. 
1e, R = n-Bu <1 88 71 80 (S) <1 12 n.d. 
1f, R = i-Bu >99 nr(d) - - - - - 
1g, R = n-Pent <1 98 85 88 (S) <1 <1 n.d. 
1h, R = Ph >99 nr(d) - - - - - 
1i, R = Bn 10 60 48 92 (R) 5 25 58 (R) 
[a] Conversions calculated by GC analysis of the crude mixture after 72 h reaction time after treatment with CH2N2. [b] 
Isolated yield. [c] Enantiomeric excesses calculated by GC or HPLC analysis on a chiral stationary phase after treatment with 
CH2N2. [d] n.r.: no reaction product was observed. 
 
Diols 1 f and 1 h were recovered unreacted from the reaction medium: the presence either 
of a branched alkyl chain or of an aromatic ring directly linked to the carbon atom in position 
2 seems to sterically hinder the enzymatic activity of A. aceti. Nearly quantitative 
conversions were obtained with diols 1 a and 1 g, showing a methyl and a n-pentyl 
substituent in position 2, respectively. The ethyl-substituted diol 1 b afforded the lowest 
conversion values. 
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The effect of substrate loading was investigated for the oxidation of compound 1 g. After 72 
h, conversion was quantitative when the substrate concentration was 1.0 g L−1, whereas it 
decreased to 77 % and 64 % starting from 2.0 and 3.0 g L−1 of compound 1 g, respectively. 
As for the observed enantioselectivity of the reaction, the (R)-enantiomers of 
compounds 2 were obtained with decreasing ee values as the length of the alkyl chain at 
position 2 increased from methyl to n-propyl. An inversion of stereoselectivity was 
promoted by the reduced flexibility of the three-carbon chain of the 2-allyl derivative 1 d, 
affording (S)-2 d with modest enantiomeric purity. The same (S) selectivity was maintained 
for the n-butyl and n-pentyl-substituted compounds with higher ee values (80 and 88 %, 
respectively). The presence of a benzyl group was found to promote the oxidation of the 
primary alcohol affording the (R)-enantiomer of 2 i with ee=92 %. 
As the reaction is known to occur according to a two-step sequence with an intermediate 
aldehyde, the enantioselectivity is controlled by the PPQ-ADH acting during the first step. 
A tentative explanation for the observed inversion of enantioselectivity can be proposed by 
comparing the steric hindrance of the alkyl substituent R in position 2 and that of the 
CH2OH, which is left unreacted. If R is small (i.e., Me, Et, n-Pr), the (R)-enantiomer of 
compound 2 is favoured. When the bulkiness of R increases (i.e., allyl, nBu, n-Pent), a 
switch to (S) selectivity is observed. The presence of the aromatic ring in diol 1 i induces a 
different orientation of the substrate in the enzyme active site with respect to the other alkyl-
substituted diols. 
The ee values of the desired hydroxymethyl derivatives 2 were found to be rather 
satisfactory, especially compared with the values reported in the literature, as is hereafter 
summarized. Compounds (R)-2 a and (S)-2 e were obtained with enantiomeric excesses very 
close to the one previously observed with other strains of Acetobacter.[11, 12] Both 
enantiomers of the ethyl esters of 2 b, e, g and i have been previously obtained in 
enantiomerically enriched form by enzyme-mediated reductions of the corresponding 2-
formylderivatives by the Kaneka corporation,[15] with the following ee values being 
reported: (R)-2 b 37–89 %, (R)-2 e 75–97 %, (R)-2 g 87 % and (R)-2 i 72–93 %. The Evans 
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oxazolidinones procedure has been employed by SmithKline Beecham[16] and 
Theravance[17] for the synthesis of derivatives (R)-2 g and (R)-2 i to be used in the 
preparation of antibacterial APIs, although no indication of the enantiomeric purity was 
provided. The same strategy has been employed by Banyu Pharmaceutical Co. to prepare a 
suitable derivative of (R)-2 d[18] as a single enantiomer for the synthesis of opioid receptor-
like 1 antagonists. In 2004, Sibi et al.[19] reported the radical alkylation of hydroxyacrylates, 
obtained by Baylis–Hillman reaction, with alkyl iodides in the presence of chiral Lewis acids 
as catalysts to give hydroxymethyl compounds of type 2. This procedure afforded both the 
enantiomers of 2 c with ee values from 40 % to 75 %. The direct enantioselective 
hydroxymethylation of aldehydes, by using α,α-diphenylprolinol trimethylsilyl ether as an 
organocatalyst, has been described to afford α-substituted-β-hydroxyaldehydes, which were 
further converted to the corresponding hydroxy acids 2 by Pinnick oxidation.[20] According 
to this method, (R)-2 c with 93 % ee was obtained. BASF described the opening of racemic 
oxetan-2-ones by alcohols in the presence of a lipase as a method to obtain enantiopure esters 
of compounds 2 b, c and e,[21] with the disadvantage that, being a kinetic resolution, it 
occurred with loss of at least 50 % of the starting material. 
The value of the oxidative desymmetrisation herein described is that it represents a 
biocatalysed enantioselective synthesis, with creation of the stereogenic centre during the 
reaction under the enzyme control, avoiding the use of external chiral auxiliaries to be 
introduced and then removed at the end of the procedure. 
Determination of the absolute configuration of hydroxymethylalkanoic acids 
The absolute configuration of hydroxymethylalkanoic acids 2 a (the (R)-enantiomer of 
which is commercially available), b, c and e, and of the methyl esters of 2 a and b was 
known (see the Experimental Section for the corresponding values of optical rotatory power 
and literature references). In the case of derivatives 2 b and c, showing very low values of 
optical activity, further confirmation of the (R)-configuration was obtained by preparing two 
samples of the methyl esters of (S)-2 b and c, that is, (S)-5 b and c, respectively, according 
to a known procedure[22] based on the reduction of formyl derivatives 6 b and c (Scheme 
3) by baker's yeast (BY) in aqueous medium, followed by transesterification in methanol 
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with a catalytic quantity of sulphuric acid. The HPLC analysis on a chiral stationary phase 
of the 3,5-dinitrobenzoates 7 b and c of compounds 5 b and c, obtained from the products 
of either A. aceti oxidation or BY reduction, were in agreement with the assignment of (R)-
configuration of those obtained by oxidation of the achiral diols. 
 
Scheme 3. Assignment of the absolute configuration of (S)-2a-b. i) BY, water, glucose; ii) 
MeOH, cat. H2SO4; iii) 3,5-dinitrobenzoyl chloride, Et3N, CH2Cl2; iv) A. aceti, water. 
 
The absolute configuration of derivative (−)-2 d was established by converting it into 
derivative (S)-7 c by hydrogenation of the allyl chain (H2, Pd/C), esterification (MeOH, cat. 
H2SO4) and acylation (3,5-dinitrobenzoylchloride, Et3N, CH2Cl2). 
The absolute configuration of derivative (−)-2 g was established to be (S) by chemical 
correlation by converting (−)-2 g into (+)-(R)-8 according to the reaction sequence reported 
in Scheme 4. 
 
87 
 
Scheme 4: Assignment of the absolute configuration of (R)-2d. i) A.aceti, water; ii) MeOH, 
cat. H2SO4; iii) MsCl, Et3N, CH2Cl2; iv) LiAlH4, THF. 
 
Side reactions of the oxidative desymmetrisation 
During the oxidation reactions of diols 1 b–e and i, the formation of the dehydrated 
product 3 and of the corresponding reduced 2-methyl alkanoic acid 4 was observed (Scheme 
1 and Table 1), whereas oxidation of 1 a and 1 g afforded the corresponding 
enantiomerically enriched hydroxy acid as the only detectable product. Mixtures of 
derivatives 3 and 4 were isolated from the reaction medium after the bio-oxidations of 
diols 1 b and 1 c. The two components of each mixture were identified by GC/MS and by 1H 
NMR spectroscopy. Compounds 4 d and 4 e could be detected only by GC/MS analysis of 
the corresponding crude residues obtained after the extraction procedure. (R)-2-Methyl-3-
phenylpropanoic acid (4 i) showing an ee value of 58 % could be isolated as a pure 
compound from the reaction mixture when diol 1 i was the starting substrate. 
The formation of these 2-methylalkanoic acids was supposed to involve an enzyme-
mediated transformation, which was mainly based on the evidence that compound 4 i was 
obtained enriched in the (R)-enantiomer form. Carbon–oxygen bond cleavage is a very 
common reaction in biological systems, and several mechanisms have evolved in nature to 
promote deoxygenation procedures.[23] Deoxysugars are important examples of compounds 
obtained by this kind of reaction, through a multi-step sequence that varies according to the 
position of the OH group to be removed.[24] For example, C-6 deoxygenation of D-hexoses 
is catalysed by a NAD+-dependent nucleotidyldiphosphohexose (NDP-hexose) 4,6-
dehydratase (Eod), belonging to the short-chain dehydrogenase/reductase family, and it 
consists of three sequential steps (Scheme 5 a):[25] i) oxidation of the OH group in position 
4 of NDP-D-glucose to give NDP-4-ketoglucose with formation of NADH; ii) elimination 
of water across C-5 and C-6; iii) final reduction of the 4-keto-Δ5,6-glucose intermediate by 
NADH to afford NDP-6-deoxy-4-keto-glucose. 
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Scheme 5. Mechanism of the C-6 deoxygenation of d-hexoses (a) and an analogous tentative 
pathway for the explanation of the formation of deoxygenated products 3 and 4 (b). 
We hypothesised a similar pathway to explain the formation of deoxygenated 
compounds 3 and 4 (Scheme 5 b): oxidation of the primary alcohol to the intermediate 
hydroxymethyl aldehyde, dehydration to α-methylenic aldehyde, reduction of the C=C 
double bond, and oxidation to acid 4. The oxidation of the intermediate unsaturated aldehyde 
can afford derivative 3. 
Because of the highly oxidative character of the culture broth, and the remarkable reactivity 
of the formyl group towards oxidation, the hypothesised aldehyde intermediates could not 
be detected during the reactions of diols 1. To support this dehydration mechanism, feeding 
experiments (72 h reaction time) were performed by using the unsaturated and saturated 
aldehydes that are precursors of acids 3 b and 4 b (R=Et). When 2-ethylacrolein was added 
to the A. aceti culture in a concentration of 1.0 g L−1, a mixture containing 5 % saturated 
acid 4 b and 95 % unsaturated acid 3 b was recovered. The use of a lower concentration of 
the aldehyde (0.1 g L−1) afforded a final reaction mixture containing a higher amount of 
acid 4 b (44 %) besides 3 b (56 %). When 2-methylbutanal was fed directly into the 
fermentation medium, either at 0.1 or 1.0 g L−1 concentration, complete oxidation to the 
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corresponding carboxylic acid 4 b was observed. The alternative pathway, in which the 
hydroxy acid 2 b is dehydrated to 3 b and then hydrogenated to 4 b, was excluded on the 
basis of the fact that no alkene reduction was observed when commercially available acrylic 
acid 3 b was added directly to the A. aceti culture. 
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Conclusions  
Acetic acid bacteria are non-pathogenic microorganisms and are readily available owing to 
their widespread use in the food industry, which makes them ideal candidates for biocatalytic 
applications. In this case, the Acetobacter-mediated desymmetrisation of achiral 1,3-diols 
has been shown to be an effective procedure for the preparation of enantiomerically enriched 
hydroxymethyl alkanoic acids. The interest in these derivatives increased considerably in 
the last few years because they can be converted into α-substituted-β-lactone APIs, [26] 
currently studied as caseinolytic protease (ClpP) inhibitors, to develop a novel therapeutic 
strategy to simultaneously sensitize pathogenic bacteria to host defences and pharmaceutical 
antibiotics. For this purpose, the required hydroxymethyl acid derivative is generally 
obtained with the use of the Evans chiral oxazolidinones auxiliary. The Acetobacter-
mediated oxidation occurs under mild operative conditions, in aqueous solution at room 
temperature, requiring neither the use of complex purpose-made chiral catalysts, nor the 
assistance of chiral auxiliaries that are to be removed after the creation of the stereocentre. 
The starting 1,3- diols are readily prepared by a common synthetic sequence, which can be 
easily extended to the preparation of specific compounds. An interesting change of 
enantioselectivity from (S) to (R) was observed when the length of the linear alkyl chain in 
position 2 of the starting diol increased from three to four carbon atoms. Very few data are 
reported in the literature on the stereochemical course of the A. aceti-mediated oxidation, 
and most of them refer to the kinetic resolution of racemic secondary alcohols.[27] Thus, 
this work lays the groundwork for a more detailed investigation of the steric and electronic 
effects controlling the orientation of the starting diol in the PPQADH active site, and finally 
influencing the stereochemical outcome of this oxidative desymmetrisation. Further study 
will be devoted to investigate the hypothesised dehydration pathway and optimise the 
reaction conditions to inhibit the formation of deoxygenated compounds 3 and 4. 
Preliminary experiments performed by using immobilized A. aceti cells have produced 
interesting results in terms of increased conversion and reduction of side products. 
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Abstract 
The chemoenzymatic flow synthesis of enantiomerically pure captopril, a widely used 
antihypertensive drug, is accomplished starting from simple, inexpensive, and readily 
available reagents. The first step is a heterogeneous biocatalyzed regio-and stereoselective 
oxidation of cheap prochiral 2-methyl-1,3-propandiol, performed in flow using immobilized 
whole cells of Acetobacter aceti MIM 2000/28, thus avoiding the use of aggressive and 
environmentally harmful chemical oxidants. The isolation of the highly hydrophilic 
intermediate (R)-3-hydroxy-2-methylpropanoic acid is achieved in-line by using a catch-
and-release strategy. Then, three sequential high-throughput chemical steps lead to the 
isolation of captopril in only 75 min. In-line quenching and liquid-liquid separation enable 
breaks in the workflow and other manipulations to be avoided. 
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Introduction 
The design and development of reproducible, environmentally benign and economical 
synthetic routes to drugs is of para-mount importance in the pharmaceutical industry, and, 
in this context, continuous-flow synthesis is receiving increasing attention.[1–3]As a result, in 
recent years, many new flow-based routes have been designed towards commercially 
available active pharmaceutical ingredients[4,5]. We herein report an efficient 
chemoenzymatic flow synthesis of captopril [(S)-1-[(S)-3-mercapto-2-
methylpropanoyl]pyrroli-dine-2-carboxylic acid, 5, Scheme 1]. Captopril is an angiotensin-
converting enzyme (ACE) inhibitor and was discovered and developed at E. R. Squibb & 
Sons Pharmaceuticals in the 1970s, and is still a widely prescribed drug for the treatment of 
hyper-tension. 
 
 
 
 
Scheme 1. Four steps chemoenzymatic synthesis of enantiomerically pure captopril 
Our flow-based synthetic route to obtain captopril includes a first biocatalyzed 
heterogeneous regio- and stereoselective oxidation reaction starting from a cheap prochiral 
diol (2-methyl-1,3-propandiol, 1)[6,7] followed, after isolation of carboxylic acid 2, by three 
sequential chemical steps. The biocatalyzed flow oxidation offers an efficient alternative for 
environmentally benign oxidations in answer to the critical economic and environmental 
issues that urgently demand greener, more atom-efficient and scalable oxidation methods.[8,9] 
The oxidation was performed using Acetobacter aceti MIM 2000/28;[10–12]this strain is able 
to completely convert the substrate into (R)-3-hydroxy-2-methylpropanoic acid (2) with an 
excellent ee (96–97%) using a conventional batch-mode biotransformation. To exploit all 
the advantages of performing (bio)catalyzed reactions in flow, in particular the high local 
concentration of the biocatalyst,[13–16] A. aceti has been immobilized as dried alginate-
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entrapped cells, that are economical, easy to prepare and can be efficiently used in a packed 
bed column.[17]. Also, importantly, the use of whole cells in biocatalytic oxidation has the 
great advantage of not requiring an additional cofactor regeneration system. The following 
three chemical steps that yield captopril under continuous flow conditions are depicted in 
Scheme 1. To achieve this continuous-flow synthesis, the reactions have been designed so 
that the excess of reagents and reaction by-products from each reaction were compatible 
with the down-stream reactions, in order to perform steps in sequence without breaks in the 
workflow and manipulation. The risks associated with exothermic reactions and quenches 
(i.e., the use and neutralization of thionyl chloride) were mitigated owing to two of the 
advantages of continuous flow over batch synthesis: 1) only a small amount of material 
relative to the overall output of the system is utilized at any given time, and 2) the large 
surface-area-to-volume ratios that allow precise reaction control through rapid heat transfer 
and mixing. Moreover, in-line liquid–liquid extractions safely neutralized and removed 
problematic reagents and by-products. 
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Experimental Section 
All reagents and solvents were purchased from Sigma–Aldrich. The continuous flow 
reactions were performed using a commercial R2C/R4 flow reactor (Vapourtec, Bury St. 
Edmunds, Suffolk, UK) equipped with Omnifit glass columns (15 mm i.d. x 100 mmlength) 
and PFA reactor coils (2 and 10 mL, respectively). The R2C unit is the pumping unit that 
contains two adapted Knauer pumps, which are able to pump highly concentrated and 
corrosive acids. R4 is the heating unit with four heating positions. The additional HPLC 
pumps necessary to perform the overall synthesis were provided by another R2 + /R4 flow 
reactor (Vapourtec) and by two external pumps (ThalesNano). The temperature sensor sits 
on the wall of the PFA tubing. The pressure was controlled by using two 100 psi BPRs. In-
line liquid–liquid extractions were per-formed using a Zaiput separator. 1H NMR and 13C 
NMR spectra were recorded with a Varian Mercury 300 (300 MHz) spectrometer. Chemical 
shifts (б) are expressed in ppm, and coupling constants (J) are expressed in Hz. The molar 
conversion of the biotransformation was determined by HPLC analysis using a Luna NH2 
100 Å column (250 mmx4.6 mm, particle size 5 µm, Phenomenex, Aschaffenburg, 
Germany) and a Biorad refractor index detector with an acidic aqueous KH2PO4 buffer (20 
mm, pH 2.7) as the mobile phase (flow rate 0.2 mL min-1). The samples (40 mL) were 
injected as soon as collected and without further treatment. The enantiomeric composition 
of 2 was determined by gas chromatographic analysis of the corresponding methyl ester 
[methyl (R)-3-hydroxy-2-methylpropionate: tr= 3.6 min], obtained after treatment with 
diazomethane, using a chiral capillary column (diameter 0.25 mm, length 25 m, DMePeBeta-
CDX-PS086, MEGA, Legnano,Italy). Optical rotation determinations were performed using 
a Jasco P-1010 spectropolarimeter coupled with a Haake N3-B thermostat. MS analyses 
were performed on a Varian 320-MS triple quadrupole mass spectrometer with an 
electrospray ionization(ESI) source. Microanalyses (C, H, N) were within ± 0.4% of 
theoretical values. 
Strain Preparation 
The A. aceti MIM 2000/28 strain was routinely maintained on GYC agar plates [glucose (50 
gL-1), yeast extract (10 g L-1), CaCO3(30 g L-11), agar (15 gL-1), pH 6.3] at 28 °C. Strain was 
inoculated into 100 mL Erlenmeyer baffled flask containing GLY medium[yeast extract (10 
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gL-1) and glycerol (25 gL-1), pH 5; 20 mL]. After growth for 24 h (shaking at 150 rpm, 28 
°C), the liquid culture was entirely used to inoculate a 1 L Erlenmeyer baffled flask 
containing GLY medium (150 mL). Flasks were grown for 24 h at 28 °C, with shaking at 
150 rpm. Preparation of Dry Alginate Beads Gel beads were prepared by ionotropic gelation, 
by following a protocol previously developed by us:[17]a 4%(w/v) sodium alginate solution 
was prepared in distilled water and stirred until a homogeneous clear solution was formed. 
The solution was allowed to settle for 2 h in order to eliminate the air bubbles. The alginate 
solution was then gently mixed in a 1:1 (w/w) ratio with a suspension of A. aceti cells (40 
ODmL-1) in sodium acetate buffer (20 mm, pH 6). The resulting mixture was then pumped 
drop wise into a slightly agitated CaCl2solution (0.2 M). Calcium alginate beads were 
agitated for 20 min, then filtered, washed with deionized water and dried at 25 °C for 16 h. 
Synthesis of (R)-3-Hydroxy-2-methylpropanoic Acid (2) 
Dry alginate beads (400 mg) were packed into a glass column (i.d.15 mm) and swelled until 
their volume tripled by flowing acetate buffer (20 mm, pH 6) through the column (flow rate: 
400 mLmin-11, 60 min). The final volume of the bed was 5.1 mL. Air was delivered at 17 
psi; its flow was measured using the method described in Ref. [20]. To ensure a constant 
flow, a BRP (40 psi) was applied before the air tank. An aqueous solution of 1 (1 g L-1, 40 
mL) was pumped at 60 mL min-1, joining the airflow at the T-junction, before entering the 
column in which the oxidation occurs in approximately 10 min. The exiting flow stream was 
directed into a decompression column. A BPR (5 psi) ensured a constant and controlled flow 
of aqueous phase leaving the column. The aqueous stream was directed into a column filled 
with Ambersep 900 OH resin (2 g) and, after washing the column with water (20 mL,0.5 mL 
min-1), the trapped acid was released by flowing HCl (1 N,5 mL). After lyophilization, 
compound 2 was isolated as pale yellow oil (42 mg). To obtain a larger amount of 2, 1.6 g 
of alginate beads were used, with a reactor volume of 20 mL. At this scale, 170 mg of com-
pound 2 was isolated (91% yield). [α]  =−11.55 (c=1.00 in EtOH); 1H NMR (300 MHz, 
CDCl3): δ = 1.22 (d, J=7.4 Hz, 3 H), 2.10 (s, 1 H), 2.68–2.80 (m, 1 H), 3.75 (d, J=6.0 Hz, 
2 H), 5.70 ppm (br s, 1 H); 13C NMR (75 MHz, CDCl3): δ = 13.2, 41.6, 64.0, 180.1 ppm; 
MS (ESI): m/z: 102.9 [M–H]−;[21] HPLC analysis: 1, tr=22 min; 2, tr=18 min. 
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Synthesis of (R)-3-Chloro-2-methyl propanoyl Chloride (3) 
A solution of 2 (52 mg, 0.5 mmol) was prepared in anhydrous toluene (410 mL). Imidazole 
(3.5 mg, 0.1 equiv) and DMF (50 µL) were added to the solution. A second solution of 
thionyl chloride (125 mL, 3.5 equiv) was prepared in anhydrous toluene (375 mL). The two 
solutions were mixed into a T-piece and flowed through a 10 mL reactor coil according to 
the conditions reported in Table 1. A 200 psi backpressure regulator was applied to the 
system. The exiting solution was collected, the solvent was evaporated under reduced 
pressure to yield 3 as a crude oil, which was analyzed by 1H NMR spectroscopy. 1H NMR 
(300 MHz, CDCl3): б =1.42 (d, 3 H), 3.20–3.31 (m, 1H), 3.66–3.80 ppm (m, 2 H). 
Synthesis of (S)-1-[(S)-3-Chloro-2-methylpropanoyl]pyrroli-dine-2-carboxylic Acid (4) 
A solution of compound 3 (70 mg, 0.5 mmol) in toluene (0.5 mL) was prepared. A second 
solution of l-proline (115 mg, 2 equiv) and NaOH (60 mg, 3 equiv) was prepared in water 
(0.5 mL). The two solutions were flowed at a total rate of 2 mL min-1 through a 2 mL reactor 
coil, that had been washed with a mixture of toluene and water, at room temperature. The 
aqueous phase was acidified to pH 2 by introducing a flow of HCl (6 N, 1 mL min-1) and the 
resulting biphasic system was mixed using a T-junction into an EtOAc stream (1 mL min-1) 
to perform in-line extraction. The two phases were separated in-line using a Zaiput liquid–
liquid separator. A 200 psi backpressure was applied to the system. The organic solvent was 
dried over anhydrous Na2SO4and evaporated under reduced pressure to yield 4 as a crude 
solid, which was analyzed by 1H NMR spectroscopy. [α] =−103.6 (c=1 in EtOH); 1H NMR 
(300 MHz, CDCl3): δ=1.24 (d, 3 H, J=7.0), 2.02–2.18 (m, 4 H), 2.96–3.08 (m, 1 H), 3.44–
3.51 (m, 1 H), 3.57–3.72 (m, 2 H), 3.81 (t, 1 H, J=10.4), 4.62–4.69 (m, 1 H), 11.30 (br s, 
1 H); 13C NMR (75 MHz, CDCl3): δ=15.8, 24.9, 27.7, 41.3, 45.8, 47.7, 59.6, 173, 175 ppm; 
MS (ESI): m/z: 217.9 [M–H]−; elemental analysis calcd (%) for C9H14ClNO3: C 49.21, H 
6.42, N 6.38; found: C 49.00, H 6.31, N 6.50. 
Synthesis of (S)-1-[(S)-3-Chloro-2-methylpropanoyl]pyrroli-dine-2-carboxylic Acid 
(Captopril, 5) 
A solution of compound 4 (22 mg, 0.1 mmol) in toluene (0.1 mL) was prepared. A second 
solution of NaSH (21 mg, 3 equiv) was prepared using degassed water (0.1 mL). The two 
solutions were flowed through a 10 mL reactor coil. A 200 psi backpressure was applied to 
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the system. Reaction time and temperature were optimized, as reported in Table 2. The 
aqueous phase was acidified at pH 2 by introducing a flow of HCl (2 N) and the resulting 
biphasic system was mixed using a T-junction into an EtOAc stream to perform inline 
extraction. The two phases were separated inline using a Zaiput liquid–liquid separator. The 
organic solvent was dried over anhydrous Na2SO4 and evaporated under reduced pressure to 
yield 5 as a pale yellow crude solid, which was analyzed by1H NMR spectroscopy. [α] 
=−128.5 (c=1 in EtOH); lit=−129.4 (c=1.35 in EtOH at 22 °C);[18] 1H NMR (300 MHz, 
CDCl3): δ=1.24 (d, J=7.0 Hz, 3 H), 1.58 (t, J=9.2 Hz, 1 H), 2.02–2.18 (m, 4 H), 2.43–2.51 
(m, 1 H), 2.79–2.90 (m, 2 H), 3.55–3.71 (m, 2 H), 4.62–4.69 (m, 1 H), 11.30 ppm (br s, 1 H); 
13C NMR (75 MHz, CDCl3): δ=17.0, 20.8, 24.7, 27.4, 42.5, 47.4, 59.2, 173.0, 175.0 ppm; 
MS (ESI): m/z: 215.9 [M–H]−; elemental analysis calcd (%) for C9H15NO3S: C 49.75, H 
6.96, N 6.45; found: C 49.60, H 6.89, N 6.52. 
Three-Step Continuous-Flow Synthesis of Captopril (5) 
A solution of 2 (156 mg, 1.5 mmol) in anhydrous toluene (1.23 mL) was prepared. Imidazole 
(10.5 mg, 0.1 equiv) and DMF (150 µL) were added to the solution. A second solution of 
thionyl chloride (375 µL, 3.5 equiv) was prepared using anhydrous toluene (1.12 mL). The 
two solutions were flowed through a 10 mL coil reactor that was maintained at 110 °C, with 
a residence time of 30 min (total flow rate 0.33 mLmin-1). Then, the exiting flow was merged 
at a T-junction with an aqueous solution (1.5 mL) of l-proline (2 equiv) and NaOH (7 equiv). 
This then entered a 2 mL reactor coil, maintained at room temperature with a residence time 
of 3 min (total flow rate 0.66 mLmin-1). The aqueous phase was acidified to pH 2 by adding 
a flow stream of HCl (6 N, 0.33 mLmin-1) and the resulting biphasic system was mixed using 
a T-junction into an EtOAc stream (0.33 mL min-1) to perform an in-line extraction. The two 
phases were separated in-line using a Zaiput liquid–liquid separator. The organic phase was 
collected in a vial acting as a substrate reservoir for the final nucleophilic substitution 
reaction. The organic phase was pumped and mixed with a solution of NaSH (c = 1.5 M, 3 
equiv) in degassed water, and entered a 10 mL coil reactor maintained at 125 °C for 30 min 
(total flow rate 0.66 mL min-1). A 200 psi backpressure was added to the whole system. The 
exiting flow was then acidified to pH 1 with HCl (2 N) and a continuous extraction with the 
Zaiput liquid–liquid separator was performed. The organic solvent was dried over anhydrous 
Na2SO4 and evaporated under reduced pressure to yield a crude material that was purified 
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by column chromatography (dichloro-methane/methanol 98:2) to yield captopril, which was 
crystallized from ethyl acetate/hexane (1:1, total volume 1 mL; 160 mg, 50 %). 
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Results and Discussion 
First, commercially available diol 1 (1 gL-1in 20 mm acetate buffer, pH 6) was successfully 
oxidized with dried alginate beads of Acetobacter aceti MIM 2000/28 with high enantio and 
regioselectivity. The immobilized cells were prepared according to a protocol recently 
reported by us,[17]packed into a glass column (inner diameter 15 mm) and swelled by flowing 
buffer through the column until their volume tripled. No release of catalyst in the exiting 
flow stream was observed. The oxygen supply, essential for cofactor recycling, was ensured 
by means of a segmented air–liquid flow stream (for details, see the Experimental Section) 
formed before contact with the immobilized biocatalyst (Scheme 2). 
 
 
 
 
 
Scheme 2. Biocatalyzed heterogeneous oxidation of prochiral 2-methyl-1,3-propandiol, (1) 
and in line purification of the product through a catch and release protocol. 
The reaction reached 95% conversion in only 10 min with an excellent ee (96–97%), as 
determined by chiral gas chromatography. The stability of the biocatalyst under continuous 
work was assessed by performing the biotransformation under the conditions reported in the 
Experimental Section. Using 400 mg of immobilized biocatalyst, a total volume of 
approximately 50 mL was collected. Samples collected at different times were analyzed by 
HPLC and the results obtained in terms of conversion were comparable over time, indicating 
good stability under continuous work conditions. The maximum conversion (95%) was 
observed for the first 35 mL of collected solution. Then, the conversion slowly decreased to 
80% in the following fractions. Therefore, the use of dried alginate beads in flow offers good 
stability over the time, giving 95% conversion for approximately 10h of continuous work. 
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However, the buffer flow stream, even if characterized by low ionic strength (20 mm), might 
interfere with the alginate bead structure, which could slowly release the biocatalyst and 
consequently decrease the conversion. Attempts to perform in-line acidification and 
extraction with an organic solvent (e.g., EtOAc) using a liquid–liquid separator were not 
successful due to the high hydrophilicity of the obtained carboxylic acid 2. Consequently, 
we exploited a catch- and-release strategy using a column packed with Ambersep 900 OH 
resin that trapped the acid, leaving unreacted starting material in the exiting flow stream. 
Compound 2 was then released from the resin by using 1 N HCl and lyophilized. Then, 
starting from the isolated compound 2, we studied the chlorination reaction with thionyl 
chloride with heating in a pressurized system to effect both the formation of the acid chloride 
and the direct chlorination of the primary alcohol (Scheme 3). A 200 psi backpressure 
regulator (BPR) was used to prevent outgassing. The possibility of conducting such an 
exothermic reaction under heating conditions demonstrates one of the operational 
advantages and capabilities of continuous flow synthesis over analogous batch processes 
that require cooling during the addition of thionyl chloride. 
 
  
 
 
Scheme 3. The chlorination reaction using a 10 mL reactor coil. BPR: 200 psi. Solvent, 
temperature and residence time were optimized as summarized in Table 1. 
The reaction was tested in anhydrous toluene, THF, and CH2Cl2; the reaction proceeded 
similarly with all the selected solvents. Therefore, toluene was selected and a 1 m solution 
of compound 2 was used. An excess of thionyl chloride (3 equiv, 3 m solution in toluene) 
was necessary to drive the reaction to completion. A catalytic amount of imidazole and 10 % 
DMF (v/v) were added to the solution of 2. The use of DMF has a double effect: first, it 
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favored the reaction due to the formation of the Vilsmeier reagent and, second, it increased 
the solubility of the starting material in toluene. Different reaction conditions were then 
tested and they are summarized in Table 1. The outcome was monitored by 1H NMR 
spectroscopy after evaporation of the solvent. If no complete conversion was observed, the 
starting material 2 and/or the acid chloride (without substitution of the hydroxy group) were 
identified as the only impurities. We also tried the reaction using only DMF to prepare the 
solution of 2 (Table 1, entries 6 and 7) and observed complete conversion at 100 °C in 30 
min. 
Table 1. Conditions tested for the chlorination reaction.[a] 
Entry T [°C]   tr [min] Yield 3 [b] (%) 
1[c] 85 60 80 
2[c] 100 60 100 
3[c] 110 30 100 
4[c] 125 15 70 
5[c] 150 15 70 
6[d] 100 30 100 
7[d] 100 15 85 
1. [a] See the Experimental Section for the reaction conditions. [b] Conversions were determined by 1H NMR, 
after evaporation of the solvent. [c] Flow stream A: 2 (1 M) in toluene/DMF (9:1) containing 0.1 equiv 
imidazole; flow stream B: SOCl2 in toluene (3 M). [d] Flow stream A: 2 in DMF containing 1 % imidazole; 
flow stream B: neat SOCl2. 
  
Intermediate 3 was then submitted to amide coupling with l-proline (Scheme 4). Because the 
final goal was to have all the synthetic steps in-line, without a break in the workflow, we 
decided to use for this reaction the same solvent as in the previous step. 
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Scheme 4. The coupling reaction using a 2 mL reactor coil. Pressure: 200 psi 
Thus, 3 was dissolved in toluene (1 M solution), mixed with an aqueous basic (NaOH, 3 
equiv) solution of L-proline (2 M solution, 2 equiv) and flowed into a 2 mL perfluoroalkoxy 
alkane (PFA) reactor coil. The reaction was performed at room temperature, without cooling, 
and was rapid, giving full conversion within only 1 min of residence time. In-line 
acidification to pH 2 followed by a liquid–liquid separation using a Zaiput separator were 
performed, affording the desired product 4. 
The final step was the nucleophilic substitution of the chlorine with the thiol group (Scheme 
5). Again, we used toluene as an organic solvent and the reaction was studied in a biphasic 
system toluene/degassed water, used to reduce the possible formation of oxidized 
byproducts. 
 
 
 
 
Scheme 5. The nucleophilic substitution using a 10 mL reactor coil. Pressure:200 psi 
To perform the substitution, an excess of NaSH (3 equiv) was efficiently used. An in-line 
acidification followed by a liquid–liquid separation allowed captopril to be obtained from 
the organic phase that was evaporated and analyzed by 1H NMR spectroscopy. Temperature 
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and residence time were optimized and the results are summarized in Table 2. The reaction 
was complete in 30 min at 125 °C (Table 2, entry 4). 
Table 2. Conditions tested for the nucleophilic substitution.[a]  
Entry T [°C]   tr [min] Yield 3 [b] (%) 
1 50 60 70 
2 80 60 90 
3 100 60 93 
4 125 30 100 
5 125 15 75 
[a] See the Experimental Section for the reaction conditions. [b] Conversions were determined by 1H NMR 
spectroscopy after evaporation of the solvent. 
 
 
Once the reactions were separately optimized, we next developed a continuous multistep 
production of captopril that would be sufficiently robust for multiple hours of continuous 
work (Scheme 6). We assembled the system such that the product stream from the 
chlorination reaction, obtained using the conditions reported in Table 1 (entry 3), was 
immediately submitted to the coupling reaction in a toluene/water biphasic system, as 
described above. To this end, first we evaluated the amount of NaOH necessary to neutralize 
the excess acid from the chlorination step. The T-junction was cooled to 0 °C for the 
neutralization and, in this way, the uncontrolled exothermic neutralization and the release of 
large quantities of HCl vapors were avoided. In this set-up, the residence time for the 
coupling reaction in the 2 mL reactor coil was approximately 3 min (Scheme 6). After 
separation of the two phases, the exiting organic solution of compound 4 was collected in a 
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vial, acting as a reservoir, and then directly used for the substitution reaction. The solution 
was pumped into a 10 mL reactor coil after mixing with the solution of NaSH in degassed 
water and heated at 125 °C. 
 
 
 
 
Scheme 6. Three-step flow chemical synthesis of captopril. BPR: 200 psi 
After in-line acidification, extraction and evaporation of the solvent, the resulting crude 
material was purified by column chromatography to yield pure captopril as a white solid. 
The 1H NMR spectrum and the optical rotation matched those reported in the literature.[18] 
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Conclusions 
The multistep flow synthesis presented here enabled captopril to be obtained in an overall 
yield of 50% after crystallization. Biocatalytic oxidation facilitated the conversion of a 
prochiral substrate into a chiral intermediate with high enantiomeric excess. Three chemical 
transformations were performed without isolation of the intermediates. The separation of co-
products, by-products, and excess reagents was achieved inline. These results clearly 
highlight the benefits of performing multi-step chemical synthesis in a flow environment. 
As a further advantage, our synthetic protocol benefits from the use of an environmentally 
friendly biocatalytic oxidation, avoiding the use of toxic chemical oxidants. The bioprocess 
might be further linked to the chemical transformations by optimizing the extraction of acid 
(2) with organic solvents, for example, using specific organic-acid-complexing carriers.[19] 
In light of a future scale-up, whereas none of the chemical steps have foreseen limitations, 
further efforts should be directed toward increasing the productivity of the first biocatalyzed 
step, which at present represents a bottleneck in the process. The new proposed protocol for 
the synthesis of captopril represents a powerful integration of biocatalysis and flow-
chemistry technology. 
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Bioprocess intensification using flow 
reactors: stereoselective oxidation of 
achiral 1,3-diols with immobilized 
Acetobacter aceti 
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Abstract 
A scalable process for the the stereoselective desymmetrisation of achiral 2-alkyl-1,3-diols 
to chiral 2-hydroxymethyl alkanoic acids was developed using a continuous-flow approach 
based on an immobilized whole cells-packed bed reactor. The use of immobilized cells of 
Acetobacter aceti MIM 2000/28 caused dramatically change substrate and product diffusion 
and thus affecting reaction rates and inhibition effects. The technological transfer from a 
classical batch system to an innovative flow system based on the use of a segmented gas-
liquid flow regime (Taylor flow) guaranteeing high mass transfer between the gaseous and 
the liquid phase allowed a significant improvement of the productivity. 
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Introduction 
Biocatalytic oxidations are attractive reactions for the organic chemist, since they often 
occur with regio- and stereoselectivity under mild conditions, utilizing environmentally 
benign oxidants (i.e., O2)1-2 and dehydrogenases of acetic acid bacteria are versatile and 
selective enzyme for alcohol oxidation;3-5 production of structurally diverse aldehydes,5-6 
aldoximes, 7 lactones,8 and carboxylic acids9-11 has been achieved using whole cells of acetic 
acid bacteria, often with high enantioselectivity.12-13 The stereoselective oxidation of achiral 
2-alkyl-1,3-diols has been previously performed using free whole cells of acetic acid bacteria 
to afford the corresponding chiral 2-hydroxymethyl alkanoic acids.14-15 Oxidation of one of 
the two enantiotopic primary alcohol allowed for desymmetrization of the achiral substrates, 
furnishing the desired 2-hydroxymethyl alkanoic acids with medium-to-high enantiomeric 
excesses. This microbial oxidation occurs under mild conditions, in aqueous solution at room 
temperature. Low productivity and side products formation were the main drawbacks of this 
biotransformation; in fact, concurrent formation of the corresponding α-methylenic alkanoic 
acids and α-methyl alkanoic acids, when the substituent in 2-position was ethyl, n-propyl or 
benzyl.15 
Different strategies can be undertaken for improving the productivity and selectivity of a 
biotransformation.16 Biocatalysts can be immobilized for enhancing stability and easy reuse; 
moreover, immobilization may dramatically change substrate and product diffusion and thus 
affecting reaction rates and inhibition effects.17 Packed bed flow micro- and meso-reactors 
can ensure high surface-to-volume ratios, thus providing high heat and mass transfer rates; 
flow packed bed reactors generally ensure that the substrate stream flows at the same 
velocity through all the reactor volume with no back-mixing.18-19 Flow-based biocatalysis 
has been recently applied for improving applications such as peptide condensation,20 
hydrolysis and formation of esters,21-26 stereoselective carbonyl reduction,27 formation of C-
C bonds,28 nucleoside, monosaccharide and oligosaccharide production,29-31 interconversion 
of carbonyls and amines using transaminases.32-33 
Transfer of the gas (air or pure O2) to the liquid phase is often the factor limiting the 
efficiency of liquid phase oxidations and a solution to increase the reaction rate is to facilitate 
mass transfer by increasing the interfacial area by applying a segmented gas-liquid flow 
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regime.34 A segmented gas-liquid flow regime (Taylor flow) is characterized by gas bubbles 
alternating with short liquid slugs and recirculation occurs within segments of the two-phase 
segmented flow, providing an efficient mass transfer between the gaseous and the liquid 
phase.34-35  
In this work, we have used immobilized cells of Acetobacter aceti MIM 2000/28 for the 
continuous flow oxidation of 2-alkyl-1,3-diols to chiral 2-hydroxymethyl alkanoic acids. 
The aim of the work was to intensify these bioconversions using a flow reactor.36 Continuous 
flow-based oxidation with immobilized cells was carried out under a segmented air-water 
flow regime for guaranteeing high mass transfer between the gaseous and the liquid phase. 
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Material and method 
General methods 
1H and 13C NMR spectra were recorded with a 400 or 500 MHz spectrometer in 
CDCl3solution at room temperature. The chemical shift scale was based on internal 
tetramethylsilane. 
GC/MS analyses were performed by using a HP-5MS column (30 m×0.25 mm×0.25 μm, 
Agilent). The following temperature program was employed: 60 °C (1 
min)/6 °C min−1/150 °C (1 min)/12 °C min−1/280 °C (5 min). 
Chiral GC analysis was performed on a Chirasil-DEX-CB (25 m×0.25 mm×0.25 μm, 
Chrompack) column or on a DAcTBSil BetaCDX column (25 m×0.25 mm×0.25 μm, 
Mega), installed on a gas chromatograph equipped with FID (carrier gas H2, constant flow 
3.7 mL min−1, tinjector=250 °C, tdetector=250 °C). Chiral HPLC analysis was performed on a 
Chiralcel OD column (4.6 mm×250 mm, Daicel) installed on an HPLC instrument with UV 
detector (λ=220 nm). 
Strain Preparation 
The A. aceti MIM 2000/28 strain was routinely maintained on GYC agar plates [glucose (50 
gL-1), yeast extract (10 g L-1), CaCO3(30 g L-11), agar (15 gL-1), pH 6.3] at 28 °C. Strain was 
inoculated into 100 mL Erlenmeyer baffled flask containing GLY medium[yeast extract (10 
gL-1) and glycerol (25 gL-1), pH 5; 20 mL]. After growth for 24 h (shaking at 150 rpm, 28 
°C), the liquid culture was entirely used to inoculate a 1 L Erlenmeyer baffled flask 
containing GLY medium (150 mL). Flasks were grown for 24 h at 28 °C, with shaking at 
150 rpm. Preparation of Dry Alginate Beads Gel beads were prepared by ionotropic gelation, 
by following a protocol previously developed by us:[17]a 4%(w/v) sodium alginate solution 
was prepared in distilled water and stirred until a homogeneous clear solution was formed. 
The solution was allowed to settle for 2 h in order to eliminate the air bubbles. The alginate 
solution was then gently mixed in a 1:1 (w/w) ratio with a suspension of A. aceti cells (40 
ODmL-1) in sodium acetate buffer (20 mm, pH 6). The resulting mixture was then pumped 
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drop wise into a slightly agitated CaCl2solution (0.2 M). Calcium alginate beads were 
agitated for 20 min, then filtered, washed with deionized water and dried at 25 °C for 16 h. 
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Results 
Biotransformations with immobilized cells 
Acetobacter aceti MIM 2000/28 was immobilized in dried alginate beads, which proved 
suited for preparing packed bed reactor used under flow conditions. Firstly, immobilized 
cells were used for the oxidation of different 2-alkyl-1,3-diols. Commercially available 2-
methyl-1,3-propandiol 1a was firstly used as current substrate for optimizing the 
biotransformation. Substrate concentration, buffer pH, and immobilized cells concentration 
were used as control parameters and optimization was carried out using a Multisimplex 
approach; conversion and enantiomeric excess of the product were the response variables. 
Optimized batch conditions (substrate 12mM in acetate buffer 20 mM pH 6.0, 40 mg/mL of 
alginate beads containing 10 mg dry weight of cells) gave (R)-3-hydroxy-2-methylpropanoic 
acid 3a with >95% molar conversion and ee = 94% after 120 minutes. Minor amounts of the 
aldehyde 2a (>10 %) were transiently observed during the reaction.  
Considering the good result obtained with 1a and the general advantages related to 
immobilized cells, it was decided to investigate the biotransformation of other achiral 2-
alkyl-1,3-diols with alginate-immobilized A. aceti under the conditions optimized for 1a 
(Table 1). 
Table 1 Oxidation of achiral 2-substituted 1,3-diols 1a–e with immobilized cells of 
Acetobacter aceti 2000/28. [a] Conversions calculated by 1HNMR of the crude mixture after 
the indicated reaction time. [b] Enantiomeric excesses measured by chiral GC or HPLC 
analysis after treatment with CH2N2. 
 
entry Substrate R 2 (%)[a] 3 (%)[a] ee (3) (%)[b] Time (h) 
1 1a Me 5 86 94 (R) 1 
2 1a Me - > 95 94 (R) 2 
4 1b Et - > 97 60 (R) 5 
5 1c n-Bu - > 97 61(R) 5 
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7 1d n-Pent - > 97 88 (S) 6 
8 1e Bn - 86 34 (R) 24 
 
All the tested substrates gave the desired chiral 2-hydroxymethyl alkanoic acid as major 
product and only small amounts of the intermediate aldehydes were observed during the 
reaction; reaction rates show a strong dependence on the steric hindrance of that C2. 
Interestingly, immobilized cells were much more chemoselective, since only traces (< 2%) 
of α-methylenic alkanoic acids and α -methyl alkanoic acids (the by-products observed with 
free cells) were detected, even at prolonged times (72 h). Compared with the biotrasformtion 
performed with the free cells,15 higher selectivity was observed. These results can be justified 
considering that cells entrapment alters substrate and product diffusion through the solid 
support, as already observed in literature using similar systems.5, 17 
Oxidation in a flow reactor 
Dry alginate beads (400 mg containing 100 mg of dry cells) were packed into a glass column 
(i.d. 15 mm) and swelled until they triplicate their volume by flowing a 20 mM acetate buffer 
(pH 6) through the column (flow rate: 400 µL/min, 60 min). The final volume of the bed 
was 5.3 mL. Optimization of the conditions in the flow reactor was carried out using 
compound 1a. No traces of biotransformation were found when the column was simply fed 
with 1 g/L solution of 1a in acetate buffer, no matter the flow rate employed. This failure 
was ascribed to lack of available oxygen in the flow stream, since in A. aceti, PQQ-
dependant alcohol dehydrogenases need molecular oxygen to regenerate the reducing 
potential of the cells. Actually, while in batch conditions the continuous agitation allows 
oxygen availability through air-liquid mixing, in the flow reactor buffer solution is confined 
inside microtubes and the initial oxygen content was insufficient to accomplish the reaction. 
In order to feed oxygen and buffer solution simultaneously and to favour oxygen dissolution 
in the aqueous phase, a segmented gas-liquid flow was applied. Pressurized air was directed 
to a T junction, where it merged with the liquid phase containing the substrate. Oxidation of 
1a run with segmented gas-liquid regime was successfully performed through the flow 
reactor containing the DALGE-immobilized cells. Temperature was kept constant at 28 °C, 
while flow rate and substrate concentration were varied (Table 2). The reaction rate rf for 
the flow reactions was calculated from the concentration of the formed product (P expressed 
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as µmol/mL), the flow rate of the liquid phase (F expressed as mL/min), and the mass of the 
biocatalyst expressed as dry weight of the cells employed (m expressed as g dry weight) 
according to Eq. 1.  
𝑟𝑓𝑙𝑜𝑤 =
[𝑃] · 𝐹
𝑚 
 (
𝑚𝑜𝑙
𝑚𝑖𝑛 ∗ 𝑔
) 
 
Table 2 Continuous enantioselective oxidation of 1a with immobilized Acetobacter aceti 
MIM 2000/28 in flow reactor. [a] Specific reaction rate was calculated according to Eq. 1. 
[b] Conversions calculated by 1HNMR of the crude mixture after the indicated reaction time. 
 
Entry [1a] (mM) Flow rate (mL/min) r[a] (mol/min gdry cells) Molar conversion 
(%)[b] 
1 12 0.015 1.80 > 97 
2 12 0.030 3.60 > 97 
3 12 0.060 4.68 65 
4 24 0.015 3.60 > 97 
5 24 0.030 7.20 > 97 
6 24 0.060 7.34 51 
7 48 0.015 4,32 60 
8 48 0.030 5.09 41 
9 48 0.060 8.07 28 
Total conversion was obtained with substrate concentration of 12-24 mM (entries 2 and 5) 
with flow rates between 15-30 µl/min, whereas at higher substrate concentrations and low 
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flow rate (entry 7) satisfactory rates were observed but without complete conversion of the 
substrate.  
The continuous flow reaction was performed over 24 hours using 24 mM 1a (Figure 1). 
Biocatalyst productivity was calculated as mmol of (R)-3-hydroxy-2-methylpropanoic acid 
3a produced per g of dry cells employed. Enantioselectivity was checked, showing the same 
enantiomeric excess (94%) observed in the batch reaction. 
 
Figure 1 Continuous enantioselective oxidation of 1a (24 mM in the flow stream) with 
immobilized Acetobacter aceti MIM 2000/28 in flow reactor. Biocatalyst productivity is 
defined as the amount of product (mmol) formed per dry weight of biocatalyst 
An in-line purification step was applied, consisting of a Ambersep 900 OH- resin, able to 
quantitatively catch the acid contained in the outstream (Figure 2).  
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Conclusions 
Desymmetrisation of achiral 1,3-diols with Acetobater aceti has been previously shown to 
be an effective procedure for the preparation of enantiomerically enriched hydroxymethyl 
alkanoic acids. Batch reaction with free cells carried out in conventional shake flasks showed 
also formation of the corresponding α-methylenic alkanoic (3) and α-methyl alkanoic (4) 
acids. Immobilization in Ca-alginate, beyond the advantages of easier work up and potential 
catalyst reusability, was found to be an excellent tool for improving the selectivity of the 
reactions with respect to the use of cell free systems. As further improvement, the oxidation 
of diols 1a was developed under continuous-flow conditions, exploiting the application of 
alginate beads in a packed-bed reactor. A segmented air-water flow regime (which ensured 
high mass transfer between the gaseous and the liquid phase) was applied allowing for high 
rates. The overall bioprocess was strongly intensified, since a remarkable reduction of the 
reactor size was achieved, while yields and biocatalyst productivity were improved. In order 
to evaluated the efficiency of the air flow-system, the immobilized cells of Acetobater aceti 
will be used with the other 2-alkyl-1,3-diols already tested in batch system. 
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Abstract 
(R)-limonene is an abundant component of citrus peel and its modification into compounds 
with higher commercial value seems very attractive. Biocatalytic hydroxylation of (R)-
limonene into (R)-perillyl alcohol is interesting, since the product is a promising candidate 
for chemo prevention and cancer therapy; moreover, perillyl  alcohol can be used as substrate 
for preparing flavours (perillaldehyde) and sweeteners (perillartine) by applying 
chemoenzymatic techniques. Hydroxylation of (R)-limonene into (R)-perillyl alcohol will 
be studied using recombinant whole cells harbouring an optimized redox gene operon 
(CYP153A6) which encodes a cytochrome P450, a ferredoxin, and a ferredoxin reductase 
from Mycobacterium sp. strain HXN-1500 by using the broad-host-range vector pET100. 
Selective and cost-effective methods for the modification of (R)-perillyl alcohol into 
perillaldehyde and perillartine will be developed. Finally, the bioprocesses will be 
intensified applying continuous flow chemistry reactors. 
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Introduction 
Limonene is one of the most common terpenes in nature, being a major component of several 
citrus oils and therefore a cheap by-product of the citrus processing industry. Depending on 
the source, the enantiomeric composition of limonene may vary: (R)-limonene (D-limonene) 
is largely predominant in orange, lemon, grapefruit, mandarin, and bergamot, whereas, 
citronella and lemongrass oils mostly contain (S)-limonene (L-limonene). Concentration of 
(R)-limonene in orange and grapefruit oils may reach 95%. (R)-Limonene is a thin and 
transparent oil obtained from the manufacturing of citrus pulp pellets, used in the 
biodegradable solvents and cleaning products and in the manufacturing of synthetic resins 
and adhesives. Citrus peel is an important food supply chain waste occurring in Italy in high 
volumes and it is suited for the combined extraction of known marketable chemicals such as 
(R)-limonene, pectin, and flavonoids1. Therefore, valorization of (R)-limonene by its 
transformation into high value-added compounds interesting for the food and pharmaceutical 
industries is a valid economical option. One way to conveniently valorise limonene is to 
perform selective hydroxylations by enzymatic means2. 
Enzymatic hydroxylation of limonene may occur at different position (Fig 1): 
monooxygenation of the double bonds at position 1,2 and 8,9 gives the corresponding 
epoxides, endocyclic hydroxylations are reported at position 3 and 6 furnishing 
isopiperitenol and carveol, respectively, whilst hydroxylation of the C7 methyl affords 
perillyl alcohol. The latter hydroxylation is attractive from a preparative point of view, since 
perillyl alcohol is a promising candidate for chemoprevention and cancer therapy3.  
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Fig. 1 Possible route for limonene oxidation 
 
Cytochrome P450 (CYP) monooxygenases are a group of enzymes able to selectively 
introduce a hydroxyl group into an unfunctionalized C–H-bonds under mild reaction 
conditions, using molecular oxygen as oxidizing agent; The set-up of CYP-based 
bioprocesses in industry is hampered by low space- time yields4, since problems like protein 
solubility, co-expression of different proteins for efficient cofactor recycling, and toxic 
effects of substrates/products must be circumvented.  
Whole wild-type cells of bacteria and fungi have been used for performing hydroxylation of 
limonene, but recovery of the corresponding alcohols or epoxides is complicated by further 
modifications, where the intermediate alcohol is further oxidized to perillic acid through the 
action of unspecific alcohol and aldehyde dehydrogenases5. Screening of 1800 bacterial 
strains showed limonene 7-monooxygenases have been found in different alkane degraders6.  
Not always the limonene 7-monooxygenases found in nature are totally selective concerning 
the position of hydroxylation. A limonene hydroxylase containing 444 amino acid residues 
has been isolated from Bacillus stearothermophilus BR388 (now Geobacillus 
stearothermophilus) and cloned in E. coli; this enzyme shows limited regioselectivity, being 
able to hydroxylate limonene at C6 (giving carveol) and C7 (giving perillyl alcohol)7. 
133 
 
Biocatalytic limonene oxidation using CYP153A6 provides an alternative and selective 
method for 7-hydroxylation of limonene. This cytochrome P450 system from 
Mycobacterium HXN 1500, including catalytic domain (CYP153; ahpG), ferredoxin 
reductase (FdR; ahpH), and ferredoxin (Fd; ahpI), has proved very selective and has been 
used for obtaining recombinant whole cells suited for the biotransformation of limonene into 
perillyl alcohol6. 
Hydroxylation of (S)-limonene to (S)-perillyl alcohol was obtained using recombinant 
bacterial cells harbouring the cytochrome P450 CYP153A6 from Mycobacterium sp. strain 
HXN-1500; among the different expression systems used, E. coli W3110 harbouring both 
CYP153A6 and the alkane transporter AlkL showed good limonene hydroxylation activities, 
giving (S)-perillyl alcohol with high selectivity8. With a different approach, Alonso-
Gutierrez et al. (2013)9 engineered a strain of E. coli with a heterologous mevalonate 
pathway and limonene synthase for production of limonene followed by coupling with a 
cytochrome P450, which specifically hydroxylates limonene to produce perillyl alcohol. 
In this project, we will employ the chemically competent strain of Escherichia coli BL21 
Star™ (DE3), which has been transformed by co-expression of the redox gene operon which 
encodes a cytochrome P450, a ferredoxin, and a ferredoxin reductase from Mycobacterium 
sp. strain HXN-1500 by using the broad-host-range vector pET100. This T7 expression 
vector allowed for high-level expression because the T7 RNA polymerase is more processive 
than native E. coli RNA polymerase and is dedicated to the transcription of the genes of 
interest. The recombinant strain so far obtained appears to be like a suited biocatalyst for the 
selective hydroxylation of (S)- and (R)-limonene into (S)- and (R)-perillyl alcohol. We will 
use the immobilized recombinant whole cells system (E. coli) for the selective hydroxylation 
of limonene in a flow reactor for the preparation of perillyl alcohol.  
Two products of the oxidation of perillyl alcohol have great interest in the food industry: 
perillyl aldehyde (or perillaldehyde used as a flavor component)10 and perillyl aldehyde 
oxime (or perillartine, a sweetener that is about 2000 times as sweet as sucrose). Perillyl 
alcohol can be further oxidize to perillyl aldehyde using alcohol dehydrogenases both as 
isolated enzymes or whole cells (Scheme 2). A green synthetic method for the one-pot 
preparation of aldoximes in water was developed11; the method is based on the combination 
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of the enzymatic oxidation of primary alcohols to aldehydes using different alcohol 
dehydrogenase of acetic acid and in situ condensation of the aldehydes with hydroxylamine. 
The main aims of this project is the preparation of recombinant strains of E. coli able to 
efficiently convert limonene into perillyl alcohol: with the following set-up of cascade 
reactions using Acetobacter aceti MIM 2000/28 for the preparation of food-valuable 
molecules such as perillaldehyde and perillartine from limonene in a continuos system. 
The overall result of the project will be a platform of chemoenzymatic transformations for 
the preparation of different molecules of practical interest starting from limonene. 
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Material and Method 
CYP153A6 cloning 
The synthetic gene encoding CYP153A6 operon has been designed and amplified using the 
following primer: 
Forward: 5’-CACCATATGACCGAAATGACCGTGGC-3’ 
Reverse: 5’-ATTGCTCGAGTCAATGCTGCGCGGC-3’ 
The amplified gene was then cloned into the pET100/D-TOPO® vector (Invitrogen) and 
correct construct sequence was confirmed by DNA sequencing (Eurofins Biolab Srl). 
Expression of recombinant CYP153A6 
Expression of the recombinant CYP153A6 operon was performed using BL21(DE3)Star E. 
coli strain harboring pET100-CYP53A6 expression vectors. Starter cultures were prepared 
growing 0,2 mL of glycerol stock of recombinant strain for overnight at 37 C in Erlenmeyer 
flasks containing 20 mL of broth with 100 mg/mL ampicillin added. Cultures were diluted 
with the same media to a starting OD600 nm of 0.1 and then incubated at 37 C on a rotatory 
shaker at 180 rpm. Cells were grow until 0.8 OD/mL and induced with 0.5 mM of IPTG and 
further incubated for 4h or 16 h at 28 °C on rotatory shaker at 180 rpm. 
The following liquid media were used: Luria–Bertani (LB: 10 g/L bacto-tryptone, 5 g/L 
yeast extract, 10 g/L NaCl), Super Broth (SB: 32 g/L bacto-tryptone, 20 g/L yeast extract 
and 5 g/L NaCl), Terrific Broth (TB: 12 g/L bacto-tryptone, 24 g/L yeast extract, 8 g/L 
glycerol, 17 mM KH2PO4 and 72 mM K2HPO4). . Experiments were carried out in 1 L 
baffled Erlenmeyer flasks containing 200 mL of liquid media. 
Crude extract preparation 
Cell pellets were re-suspended in freshly prepared sodium phosphate buffer (5 mL per gram 
of wet cells) 100 mM, pH 7, and sonicated for five cycles of 30 s each, on ice. The insoluble 
fraction was removed by centrifugation at 13,000 rpm for 1 h at 4 °C. 
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Biotrasformation condition 
Biotransformations were carried out in 5 mL screw capped tube, in a final volume of 1 ml 
of sodium phosphate buffer 100 mM, pH 7 using 9 mg of crude extract and adding 100 µL 
of stock solution of NADH ( 5 mg/mL). The substrates were added at the final concentration 
of 7 mM, dissolved in ethanol at the final concentration of 1%. Incubations were carried out 
with magnetic stirring at 30 °C. 
Analytical methods  
The conversion and stereochemical outcome of the biotransformations were determined by 
gas chromatographic analyses using a chiral capillary column (DMePeBeta-CDX- PS086, 
MEGA, Legnano, Italy), having 0.25 mm-diameter, 25 m-length and 0.25 m-thickness. With 
the following thermal gradient: starting from 80 °C increase until 110 °C in 3 minutes, 
maintain 110 °C for 9 minutes and then increase until 180 °C in 7 minutes and maintain 180 
°C for 10 minutes. 
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Result and discussion 
The chemically competent strain of Escherichia coli BL21 Star™ (DE3) has been 
transformed by expression of the redox synthetic gene operon (CYP153A6) which encodes 
a cytochrome P450, a ferredoxin, and a ferredoxin reductase from Mycobacterium sp. strain 
HXN-1500 by using the broad-host-range vector pET100. This strain Escherichia coli BL21 
Star™ (DE3) harbouring CYP153A6 will be used in this project. 
Optimization of recombinant E. coli for the transformation of limonene into perillyl 
alcohol 
The expression of the genes of interest will be indirectly analysed evaluating the perillyl 
alcohol production using the whole growing cells of the recombinant E.coli in the 
biotransformation of limonene, followed by gas-chromatography, since their differentiation 
in gel electrophoresis is difficult. Particular attention has been dedicated to the highly 
volatile limonene; for this purpose, the screening for the optimized conditions will be carried 
out using septum-sealed vials. These biotransformation have allowed to obtain a good 
amount of perillyl alcohol (between 90 mg/L and 140 mg/L after 24h) but with low 
reproducibility, may be due to highly volatility of substrate coupled with the long 
biotransformation time. In order to resolve this problem, the possibility to use the crude 
extract to perform the limonene conversion has been evaluated; this approach has allowed 
to obtain a lower biotransformation time (1h compared to 24h of the growing cells) reducing 
the evaporation effect ensure availability of substrate for all reaction time. Therefore, the 
induction study has been performed using directly crude extract as biocatalyst in the 
bioconversion of limonene. 
Initially, the recombinant CYP153A6 was expressed in standard condition: LB broth 
inducted by addiction of 0.5 mM IPTG at an OD600 nm of 0.8–1 (mid-exponential growth 
phase). Then, E. coli cells transformed with harbouring plasmid cells were incubated for an 
additional 4 h at 28 °C. Under these conditions, limonene monooxigensase specific activity 
of 1.6 mU/mg, corresponding to a volumetric productivity of 0.4 U/L and a specific 
productivity of 0.7 U/g of dry cells. 
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In order to improve the productivity of the laboratory-scale microbial process for the 
recombinant limonene monooxigenase, we first investigated the effect of medium 
composition on the growth both non-induction and induction culture at 28 °C and on their 
enzyme productivity. Growth curve evaluation was carried out monitoring the increase in 
the absorbance every hour. Three different media containing various combinations of carbon 
(glycerol) and nitrogen sources (yeast extract and tryptone), NaCl and phosphate buffer were 
analysed. 
The observed specific growth rates is higher in SB (0.45/h) respect compared to results 
obtained with LB and TB (respectively 0.38/h and 0.31/h); no significant difference was 
found making the comparison between the non-induced and induced culture. Moreover, SB 
media has allowed to get the higher biomass level in comparison to LB and TB, in particular 
high biomass production of  2.9 g/L were achieved in SB while were obtained 0.6 g/L and 
1.8 g/L respectively in LB and TB. 
Beside higher biomass production, SB medium also sustained the higher limonene 
monooxigenas expression, measured as volumetric productivity and specific productivity. 
Growing the cells using the standard induction condition, in SB medium gave up a 4-fold 
increase, in comparison to the enzyme produced under standard conditions while the specific 
activity achieved in  LB and SB medium, is comparable (Fig.1). 
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Fig. 1 Production of limonene monooxigenase using different media, expressed as U/L (blue 
bars) and U/g dry weight cell (orange bars) after induction with 0.5 mM IPTG at middle-
exponential phase (cells collected after 4 h at 28 °C). 
Since E. coli transformed cells grew with a different kinetics and reached variable level of 
biomass production depending on medium composition, limonene monooxigenase 
expression was studied with extend growth and  induction time (collecting the cells after 16 
h of induction). The results, in term of volumetric productivity and specific activity, confirm 
that the higher activity in the crude extract was achieved using SB medium, but without 
obtain an improvement compared the previous condition.  
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Conclusion and future perspectives 
The induction study will be continue evaluating different parameters such temperature, IPTG 
concentration and induction in different grow phase. The best induction condition will be 
used for immobilization study on the whole cell but also on the crude extract since has shown 
comparable results in term of perillyl alcohol production (between 100 mg/L and 130 mg/L 
after 1h). Using the immobilized whole cells guarantee the recycling of the cofactor essential 
for the reaction, but at the same, the antimicrobic effect of limonene, limit its use in high 
concentration in bioconversion. On the other hand, using the immobilized crude extract the 
main problem will be to find a method to recycle the cofactor, since the continue addition is 
too expensive in development of bioprocess. 
To ensure the continuous supply of oxygen to the reaction the continuous process will be 
developed using the air flow system previously described in the second chapter. To 
permanently ensure the availability of the hydrophobic and volatile substrate in the liquid 
phase, loss of limonene, will be avoided by using limonene-saturated air. 
Once, the flow reactor for the production of perillyl alcohol will be optimized, it will be 
studied the possibility to obtain perillaldehyde and perillartine as well. The recovered perillyl  
alcohol will be flown in a packed-bed reactor containing immobilized acetic acid bacteria, 
able to oxidize the substrate into the corresponding aldehyde.  
Alternatively, the corresponding aldoxime (perillartine) will be prepared using a one-pot 
chemo-enzymatic reaction which combines the oxidation of perillyl alcohol by acetic acid 
bacteria with condensation of the produced aldehyde with hydroxylamine. 
The continuous reactors will be optimized evaluating best conditions of flow streams, 
residence times and substrate concentrations. In these cases, an aqueous stream will be use, 
since perillyl  alcohol is partially soluble in water. 
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